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Abstract 
 
Background and Aims 
Conservation is a hallmark of inherent valuable function.  Computational analysis of 
conservation of each amino acid in a protein provides targets for future computational or 
experimental research. 
 
Carbonic anhydrases (CA) reversibly catalyze the carbon dioxide to bicarbonate reaction.  
Despite the apparent simplicity of the reaction, the α-CA protein family exists as more than 
15 different isoforms in mammals and its members are present in a wide array of tissues 
and perform a variety of functions.   
 
The overall goal of this research is identification of all residues of functional significance in 
CA-IV through utilization of gene prediction, comparative genomics, and conservation 
analysis.  The expanded goal is to make this process applicable to any protein group.  
 
 
Methods 
Automated methods were created, using Python scripting, to extract orthologs for human 
carbonic anhydrases.  Predictions were made for incomplete orthologs, and conservation 
analysis was performed on a codon alignment of the final set.  Additional python scripts 
created three dimensional (3D) models of conservation values, within specific taxa or as 
comparisons between them. 
 
 
 
  
Results 
A pipeline was created for automated gene annotation, 3D image generation, and 
comparative analysis between different taxa.  A total of 499 residue positions were altered 
in 55 carbonic anhydrase proteins from 6 isozyme types.  Key amino acids have been 
identified in a region potentially related to CA-IV ion channel binding. 
 
Conclusions 
Ka/Ks conservation analysis can be applied in a quick and automated manner to produce 
models and images from large numbers of orthologs, allowing for determination of critical 
amino acid residues in proteins. 
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1. Introduction 
At first glance, a carbonic anhydrase protein is of middling size, resembles half of an opened 
walnut, and implies no great stature in the pantheon of proteins currently categorized.  Yet, this 
protein, in a variety of incarnations, performs a basic function most essential to life in all of its 
myriad levels of complexity, that of acid/base maintainence.  It has even been proposed that CA 
activity in ancient cyano-bacteria enabled CO2 sequestration that allowed for the rise to 
dominance of higher forms of life on earth (Kupriyanova & Pronina, 2011). 
Amino acids which are conserved in a protein provide structural or functional properties.  
Examination of aligned protein sequences allows for identification of conserved amino acids.  
Ka/Ks analysis of codon-aligned DNA sequences allows a more precise determination of 
conservation.  Comparison of conservation between taxa provides a view of which amino acids 
or regions are unique to protein function within each. 
In total, 16 known isoforms of α-carbonic anhydrase help adjust acid-base balances within 
mammals.  The carbonic anhydrase IV (CA-IV) protein is present in most vertebrates and is 
linked by Glycophosphatidylinositol (GPI) to the outside surface of the cell.  It is most strongly 
expressed in the lung (Wu, et al., 2009) in air breathing vertebrates, and promotes release of 
CO2 from bicarbonate laden blood.  CA-IV is also found well expressed in many other tissues, 
including thyroid, heart, colon, retina, kidney, and cerebellum (Wu, et al., 2009). 
No conservation study of the CA-IV protein has been previously made using this number of 
sequences, the MEC codon model, or methods of taxa comparison. 
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2. Literature Review 
2.1 Carbonic Anhydrase Background 
The metal ion activated CA enzyme (metalloenzyme) catalyzes the interconversion of HCO3
-
 + 
H
+
 ↔ CO2 + H2O at a very high rate of up to 1 x 10
6
 reactions/s
 
(Lindskog, 1997).  Since the first 
investigation of its enzymatic activity, and proposal for naming as ‘Carbonic Anhydrase’ in 1932, 
the understanding of this protein family has increased dramatically
 
(Brinkman, Margaria, 
Meldrum, & al, 1932).   The Ensembl database alone categorizes over 480 CA proteins among 
61 species (primarily mammalian).  There are currently 16 carbonic anhydrase isoforms 
identified as present in mammalian species; only 15 of these are active in primates.  Three of 
these proteins are carbonic anhydrase related proteins (CARPs) and are catalytically inactive.  
The remaining active isozymes are categorized into five subgroups based on localization
 
(Leggat, Dixon, Saleh, & al, 2005): 
• Cytoplasmic (I, II, III, VII, and XIII) 
• Mitochondrial (VA and VB) 
• Secreted (VI) 
• Transmembrane (IX, XII, XIV) 
• GPI-linked (IV, XV) 
 
The CA isozymes currently present in the mammalian genome are believed to have been 
created through both whole genome and individual gene duplication.  Despite the large time 
scale of differentiation, the 
isozymes, as a group, still 
possess regions of high 
similarity.  Conversely, CA 
proteins vary in their locations 
and structure in functionally 
significant ways.  Some of the 
many noted physiological 
processes to which they 
contribute are: acid-base 
balance, respiration, 
calcification, and bone 
resorption.  They are also involved 
in the formation of cerebrospinal 
fluid, saliva, and gastric acid
 
Figure 1 - Phylogenetic tree depicting relationships of all CA isoforms current known to be 
present in humans.  Protein sequences were aligned using Clustal Omega (Sievers, et al., 2011), 
a codon alignment generated using Pal2Nal (Suyama, Torrents, & Bork, 2006). The tree was 
constructed using Maximum Likelihood analysis program PhyML (Guindon & Gascuel, 2003).  
The codon substitution model GTR was used and the parameters set using by analysis of the 
codon aligned nucleotide sequences; 100 bootstrap replications were performed.  The tree was 
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(Entrez). 
The diversity of isoforms, widespread distribution in nearly all tissue types, and presence in all 
known vertebrate genomes indicates a fundamental necessity for the enzymatic action that CAs 
provide. Proteins that are catalytically similar to α-CAs are also present in bacteria, and other 
lower life-forms, in the β, γ, δ, and ζ CA families.  Regardless of whether the presence of this 
enzymatic activity in two branches of life are due to the CA family possessing a root occurring 
before their divergence, or due to instances of convergent evolution, it is apparent that the 
reaction is vital
 
(Tashian, 1989)
 
(Gu, 1997).  Indeed, it is thought likely that CAs, from one family 
or another, are present in all living cells (Gilmour, 2010).   
Figures depicting expression values for each human CA isoform, for a variety of tissues, have 
been gathered from the BioGPS website and are located in Appendix A (Wu, et al., 2009).  As 
the measurements of expression are based on fluorescence intensity values from Affymetrix 
microarray chips, and different probe sets were used when testing different isoforms, the 
values are best interpreted when only comparing tissues from a single probeset, and therefore 
isoform.  This fact remains despite the fact that BioGPS microarray datasets have been 
normalized (using GCRMA).  However, in cases where there are significant expression value 
differences between same tissue in different probesets, assumptions become safer.  An 
abbreviated expression chart containing only those tissues and values which were greater than 
3x the mean value of expression for the whole isoform (Table 1).  While most of the CAs have a 
low level of expression in all tissues tested in the microarray, in 7 of the isoforms at least one 
tissue shows expression levels 10x that of the mean of all tissues.  
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CA 
Mean  
Exp. 
>3x mean 
Tissue(Value) 
>10x mean 
Tissue(Value) Greatest Value Kcat/s Chrom. 
Subcellular 
Localization 
or Category 
CAI 4.15 Skin(13.70)   Skin(13.70) 20 x 104 8 
Cytoplasmic 
CAII 261.4 
CD71+ Early 
Erythroid(9468.15) 
Colon(3395.85) 
CD105+ 
Endothelial(2884.00) 
CD71+ Early Erythroid(9468.15) 
Colon(3395.85) 
CD105+ Endothelial(2884.00) 
CD71+ Early 
Erythroid(9468.15) 140 x 10
4
 8 
CAIII 22.8 
Skeletal Muscle(112.85) 
Thyroid(493.25) Thyroid(493.25) Thyroid(493.25) 1.3 x 10
4
 8 
CAVII 5.7 
Atrioventricular 
Node(19.45)   Atrioventricular Node(19.45) 95 x 10
4
 16 
CAXIII 6.84 None None   15 x 104 8 
CAVI 135.6 Salivary Gland(11373.40) Salivary Gland(11373.40) Salivary Gland(11373.40) 34 x 104 1 Secreted 
CAIX 10.68       38 x 104 9 
Transmembrane 
CAXII 36.9 
Kidney(1069.25) 
Bronchial Epithelial 
Cells(182.50) 
Smooth Muscle(387.55) 
Colon(566.30) 
Caudatenucleus(161.05) 
Kidney(1069.25) 
Smooth Muscle(387.55) 
Colon(566.30) Kidney(1069.25) 42 x 10
4
 15 
CAXIV 11.1 Retina(33.65)   Retina(33.65) 31 x 104 1 
CAIV 28.3 
Thyroid(295.35) 
Lung(1054.50) 
Heart(105.05) 
Thyroid(295.35) 
Lung(1054.50) Lung(1054.50) 110 x 10
4
 17 
GPI-Linked 
CAVIII 5.3 Cerebellum(47.20)   Cerebellum(47.20) NA 8 
CARPs 
CAX 16.5 
Pineal (night)(222.94) 
Cerebellum(99.55) 
Cerebellum(Peduncles)(58
.20) Pineal (night)(222.94) Pineal (night)(222.94) NA 17 
CAXI 95.7 
Whole Brain(1030.95) 
Amygdala(776.45) 
Prefrontal Cortex(1183.15) 
Caudatenucleus(347.40) 
Parietal Lobe(305.85) 
Medualla 
Oblongata(358.75) 
Cingulate Cortex(473.15) 
Occipital Lobe(337.85) 
Temporal Lobe(434.10) 
Cerebellum(443.05) 
Cerebellum 
(Peduncles)(529.30) 
Whole Brain(1030.95) 
Prefrontal Cortex(1183.15) Prefrontal Cortex(1183.15) NA 19 
CAVA 4.73 None None   29 x 104 16 
Mitochondria 
CAVB 5.11 None None   95 x 104 X 
Table 1 - Microarray data analysis tissue expression values of significance.  Experimentally derived catalytic activity rates are shown in standardized units of 
10,000 reactions per second (Hilvo, et al., 2008).  Chromosome and sub-cellular localizations are obtained from Ensembl (Flicek, Amode, Barrell, & al., 2012).  
Rates of catalysis (Hilvo, et al., 2008). 
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2.2 Cytoplasmic CAs 
As the name suggests, this largest group of CAs is found in various locations of the interior of 
cells.  The CA1, CA2, CA3, and CA13 genes are located on chromosome number 8 in humans 
and within a ~261kb region between 86,132,816-86,393,722 (Stelzer, Dalah, Stein, & al, 2011).  
In addition to being located on the same chromosome these four genes share highest identity 
with each other, as compared to the other isoforms, indicating that they likely came about from 
duplication events on chromosome 8.  CAII has the highest average identity with the other 
cytoplasmic CAs at 58.25%, and with all other CAs at 39.6% (Hassan, Shajee, Waheed, Ahmad, & 
Sly, 2013).  Additionally, phylogenetic analysis (Figure 1) shows that these four proteins cluster 
together, while the final cytoplasmic protein CA-VII appears to be less closely related than the 
mitochondrial CA proteins. 
 
2.2.1 CA-I 
According to microarray analysis available at the BioGPS website, the carbonic anhydrase I 
protein demonstrates highest expression levels in the skin (Wu, et al., 2009) (Su, Wiltshire, 
Batalov, Lapp, & al., 2004).  However, antibody staining presented at proteinatlas.org shows 
highest expression in hematopoietic cells of the bone marrow and a subcellular localization of 
the Golgi apparatus (Uhlen, et al., 2010).  This difference in expression highlights the difference 
between these two methods with microarray generally considered to be more accurate.  CA-I is 
not secreted and therefore cannot be localized in the Golgi.  At 200,000 de/hydrations per 
second, it is the third slowest CA protein (Hilvo, et al., 2008). 
 
2.2.2 CA-II 
The carbonic anhydrase II protein is the most widely studied isoform,  has the highest rate of 
catalysis at roughly 1.4 million de/hydrations per second (Hilvo, et al., 2008), and there are over 
400 3D protein models in the Protein Data Bank that depict it.   Microarray analysis shows high 
levels of expression in early erythroid, colon, and endothelial cells (Wu, et al., 2009).  Antibody 
staining support cytoplasmic subcellular localization and indicates highest expression in 
gastrointestinal tract, kidney, and glial cells (Uhlen, et al., 2010).   
 
2.2.3 CA-III 
The carbonic anhydrase III protein has evolved to be the slowest of the CA isozymes with a rate 
of catalysis equal to 13,000 de/hydrations per second (Hilvo, et al., 2008).  According to 
microarray studies of expression the primary point of action for CA-III is in the thyroid gland, 
and secondarily in skeletal muscle (Wu, et al., 2009).  Antibody staining shows expression in 
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skeletal muscle and adipocytes (Uhlen, et al., 2010).  Likely tied to the slow rate of catalysis, 
when it comes to inhibition by sulfonamides the CA-III protein is the least reactive, with an 
acetazolamide Ki value (concentration needed to reduce catalytic activity by half) of 300,000 
nM (Lindskog, 1997) (Lehtonen, et al., 2004). 
 
2.2.4 CA-VII 
Of all the cytoplasmic α-CA genes, CA7 is the only one that does not reside on chromosome 8.  
Like most of the CA proteins, CA7 has low expression levels in most tissues, however there are 
virtually no tissues in which it is very strongly expressed.  The highest of those noted in 
microarray analysis was the thyroid gland (Wu, et al., 2009).  Antibody staining identified the 
presence of the protein in most of the tissues searched, with the strongest expression in colon, 
cervix, uterus, vulva, and esophagus (Uhlen, et al., 2010).   
 
2.2.5 CA-XIII 
For the CA-XIII protein, published microarray data at the BioGPS web database appears to have 
been normalized improperly as expression levels across many tissues are identical.  Antibody 
staining showed the presence of CA13 in a variety of cells, however, most strongly in: lower 
stomach, small intestine, appendix, colon, rectum, and gallbladder (Uhlen, et al., 2010).  At 
150,000 de/hydrations per second the CA-XIII protein is the second slowest of all (Hilvo, et al., 
2008).  Interestingly, CA-XIII was experimentally determined to be the most susceptible to 
inhibition by acetazolamide, with a Ki value of 17nM (Lehtonen, et al., 2004). 
 
2.3 Mitochondrial CAs 
Despite both of the mitochondrial CA isozymes possessing subcellular localization within 
mitochondria, they are located on two different chromosomes.  The CA5A gene is located on 
chromosome 16 and CA5B is located on the X chromosome (Flicek, Amode, Barrell, & al., 2012).  
Phylogenetic analysis of both genes in (Shah, et al., 2000) predicts that they resulted from 
duplication of a CA5 proto-gene roughly 200-300 million years ago.   
 
2.3.1 CA-VA 
Microarray data for mitochondrial CA-VA reveals no areas of high expression, but does present 
low levels of expression in all tissues and the most significant expression in the liver (Wu, et al., 
2009);  RNA-seq analysis confirms highest expression in liver, while antibody staining is not 
available (Uhlen, et al., 2010).   
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2.3.2 CA-VB 
Similar to CA-VA, microarray data for the CA-VB protein shows low levels of expression across 
many tissues, with the highest level appearing in fat tissue (Wu, et al., 2009).  Antibody staining 
for this isozyme shows expression across a variety of tissues with high levels occurring in 
hematopoietic cells of the lymph node, tonsil, and spleen (Uhlen, et al., 2010). 
 
2.4 Secreted CA 
2.4.1 CA-VI 
There is currently only a single CA that has been identified to exist in a secreted form.  
Expression levels of CA-VI in saliva dramatically exceed that of other tissues, by a factor of 
>2,000x, as determined by microarray analysis (Wu, et al., 2009); this is supported by antibody 
staining (Uhlen, et al., 2010).  A 2006 study of human patients, whose oral CA-VI was inhibited 
by acetazolamide, showed that pH was significantly lower in plaque of subjects receiving the 
inhibitor (Kimoto, Kishino, Yura, & Ogawa, 2006).  The conclusion of the experimenters was that 
CA-VI function provides protection against caries through neutralization of oral pH.  However, a 
contradictory 2011 study found that Car6 knockout mice exhibited reduced incidence of caries 
caused by oral Streptococcus mutans and cariogenic diet (Culp, et al., 2011). 
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2.5 Transmembrane CAs 
The three transmembrane localized CAs (CA-IX, CA-XII, CA-XIV) are the second largest grouping 
of active CA isoforms.  These three protein sequences possess an introductory ~289-410 amino 
acids which resides outside the cell, a ~22 amino acid transmembrane domain near the C-
terminal end of the protein sequence, finally followed by a ~24-26 amino acid region that 
resides inside the cell (Figure 2).  Unlike the cytoplasmic group, none of the transmembrane 
genes are located on the same chromosome. 
 
 
Figure 2 - Transmembrane prediction for CA-XII by TMHMM webserver (Sonnhammer, Heijne, & Krogh, 1998) 
 
2.5.1 CA-IX 
Like other CAs, microarray data shows CA-IX is expressed at low levels across many tissues, with 
highest levels in the testis and skin; general expression levels appear to be roughly twice as high 
for low expression tissues of other CAs (Wu, et al., 2009).   Antibody staining shows expression 
only in digestive system cells of stomach, duodenum, small intestine, and gall bladder in 
addition to liver (Uhlen, et al., 2010).  Of all the CA proteins the CA-IX isozyme is of the greatest 
interest as relates to cancer.  Hypoxia associated with neoplasms, in particular, has been noted 
as a trigger for CA9 gene expression. Positive signal for hypoxia-induced CA IX has been 
identified as an important biomarker for poor prognosis in several cancers
 
(Masayuki Nakao, 
2009).  In particular, recent studies have shown this holds true for the cancers derived from the 
following tissues: lung, bladder, rectum, uterine cervix, mesothelium, brain, and breast
 
(Masayuki Nakao, 2009)
 
(Sherwood, Colquhoun, & D., 2007)
 
(Rasheed, Harris, & Tekkis, 2008)
 
(Liao, Darcy, Randall, & al, 2010)
 
(Kivela, Knuuttila, Sihvo, & al, 2012)
 
(Dungwa, Hunt, Ramani, & 
al, 2012)
 
(Hsieh, Chen, Chiou, & al, 2010). 
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2.5.2 CA-XII 
In addition to low level expression across many tissues, microarray data for CA-XII shows high 
levels of expression in cells of the kidney, colon, smooth muscle, bronchial epithelial cells, and 
caudate nucleus (Wu, et al., 2009).  Antibody staining shows highest presence of CA-XII in 
appendix, colon, rectum, pancreas, and kidney (Uhlen, et al., 2010).  Like CA-IX this isozyme has 
been associated, though to a lesser extent, with a number of cancers (Table 3).   
 
2.5.3 CA-XIV 
The CA-XIV protein is shown, by microarray data, to have low levels of expression in many 
tissues with higher levels occurring in the retina.  However, the microarray data also shows 
that, as a whole, various tissues in the brain exhibited enhanced expression of the CA14 gene 
over other tissue groups (Wu, et al., 2009).  Antibody staining for the protein confirms its 
presence in many tissues with highest levels occurring in skin (Uhlen, et al., 2010).  A 2002 
study by Kaunisto et al. suggested that a primary function of CA-XIV is that it plays a 
complementary role, with CA-IV, in renal acidification (Kaunisto, et al., 2002). 
 
2.6 GPI-Linked CAs 
Glycophosphatidylinositol (GPI) is a glycolipid which, in the case of 
GPI-linked proteins, forms a link between the C-terminus of a 
protein and the membrane of a cell (Figure 3). Commonly referred 
to as an ‘anchor’, GPI is irreversibly attached to a protein inside the 
endoplasmic reticulum (ER) (Orlean & Menon, 2007).  Unlike 
transmembrane proteins, GPI penetrates only through the first half 
of the lipid bilayer, and preferentially attaches in detergent resistant 
areas called lipid rafts, so called for their infusion with cholesterol 
(Orlean & Menon, 2007) (Pike, 2009).  CA-XV is present in some 
mammals, such as mouse, rat, cat, dog, elephant, ferret, and 
squirrel (Flicek, Amode, Barrell, & al., 2012).  However, in humans it 
is present only as a pseudogene and its functionality is suspected to 
have been lost in all primates (Tolvanen, et al., 2012). 
In a previous study, to which this author contributed, phylogenetic 
analysis allowed for designation of a new group of GPI-linked CA isozymes present in fishes 
called CA-XVII (Tolvanen, et al., 2012).  In this study, analysis of GPI-linked CAs IV, XV, and XVII 
Figure 3 - Schematic diagram of 
glycophosphatidylinositol (Orlean & 
Menon, 2007) 
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revealed a significant number of probable N-glycosylation sites (defined by the Asn-X-Ser/Thr 
motif (Shakin-Eshleman, Spitalnik, & Kasturi, 1996)) present on all of the isozymes in at least 
some species; however, human CA-IV expresses none of these sites (Tolvanen, et al., 2012).  N-
glycosylation involves the addition of oligosaccharides and like GPI-linkage these addition is 
made in the lumen of the ER (Shakin-Eshleman, Spitalnik, & Kasturi, 1996).  While the function 
of N-glycosylation is unknown in relation to the GPI-linked CAs, it is potentially significant to 
note that the sites are more numerous on CA-XVII, which has only been observed in fishes and 
one lizard species. 
2.6.1 CA IV 
Microarray data shows at least low level expression in all tissues sampled, very high levels of 
CA-IV expression in the lung and significant expression in thyroid, heart, colon, and retina (Wu, 
et al., 2009).  Antibody staining confirms presence in the lung (specifically capillaries), and 
rectum (Uhlen, et al., 2010).   
The varied distribution of CA-IV indicates that it performs a number of functions.  The high 
expression of CA-IV in the capillaries of the lung indicates it is crucial in the dehydration of 
blood-born bicarbonate during the process of respiration (Zhu & Sly, 1990).  Expression of CA-IV 
in the kidney allows for reabsorption of bicarbonate (Sterling, Alvarez, & Casey, 2002).  A 2009 
study identified CA-IV as the primary sensor for CO2 in the mouth, allowing an organism to 
identify sour tastes (Chandrashekar, et al., 2009).  
Before attachment of GPI to CA-IV, inside the ER, a 28 amino acid segment is cleaved from its C-
terminus (Lindskog, 1997).  This cleavage reveals Ser-284 as the C-terminus attachment point 
for GPI.  In an experiment by Okuyama et al., a site specific mutation S284F produced an un-
cleaved and inactive CA unbound to the cell surface while the G285F mutant produced normal 
CA-IV expression (Okuyama, Waheed, Kusumoto, Zhu, & Sly, 1995).  Despite the apparent 
extracellular position of a matured CAIV, a 2013 study by Schneider et al. determined that pre-
mature CAIV protein provided intracellular activity in frog eggs before its anchorage to the cell 
surface (Schneider, et al., 2013). 
 
2.7 Carbonic Anhydrase Related Proteins 
There are three carbonic anhydrase isoforms (CA-VIII, CA-X, and CA-XI) which have no catalytic 
activity due to inactivation of the active site caused by substitution of some key residues.  
Foremost among these changes is the substitution of at least one of three Histidines (His94, 
His96, His119) which coordinate the zinc atom present in all active CAs.  Site specific mutation 
of these three positions, to His, restores catalytic activity to each CARP (Nishimori, et al., 2012).  
The function of the three CARPs has not been determined although it is a safe assumption that 
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their purpose still revolves around CO2.  Like their active counterparts the CARP proteins are 
expressed at low levels across all tissues sampled by microarray with each present in higher 
quantities in at least one specific tissue.  The CARP-VIII protein is expressed significantly in only 
one tissue, as identified in microarray analysis, the cerebellum (Wu, et al., 2009); antibody 
staining confirms cerebellum as the primary tissue and localizes to the Purkinje cells (Uhlen, et 
al., 2010).  According to microarray analysis, CARP-X is found expressed at significant levels in 
pineal gland, cerebellum, and cerebellar peduncles (Wu, et al., 2009).  The final CARP, CA-XI, is 
highly expressed in many neural tissues and retina; within the brain the more significantly 
expressed tissues are prefrontal cortex and amygdala (Wu, et al., 2009).  
CAs CA-I CA-II CA-III CA-IV CA-Va CA-Vb CA-VI CA-VII CA-VIII CA-IX CA-X CA-XI CA-XII CA-XIII CA-XIV 
CA-I 100 
              CA-II 60 100 
CA-III 53 58 100 
CA-IV 30 33 31 100 
           CA-Va 47 50 45 23 100 
CA-Vb 46 52 43 23 58 100 
CA-VI 31 33 32 26 27 24 100 
        CA-VII 50 56 49 31 48 39 34 100 
CA-VIII 39 40 38 27 33 34 28 41 100 
CA-IX 31 33 20 25 27 26 35 35 31 100 
     CA-X 26 28 27 23 24 24 19 27 27 20 100 
CA-XI 25 30 28 22 24 26 18 26 28 21 50 100 
CA-XII 35 34 31 26 27 25 32 37 28 36 21 19 100 
  CA-XIII 59 59 57 28 46 47 33 52 39 34 27 27 34 100 
CA-XIV 34 35 34 25 29 25 32 35 27 37 19 23 40 37 100 
Table 2 - Percent identity of all human CAs and CARPs [14]. 
 
2.8 Disease Related to Carbonic Anhydrase 
A variety of diseases are related to expression levels of the various carbonic anhydrase 
isoforms.  As evidenced by the preceding section nearly all of the CA proteins are expressed to 
some level in the tissues examined by microarray data analysis.  It becomes easy to speculate 
that it is due to this redundancy there are not significantly more conditions associated with this 
protein family.  However, the association with a number of cancer types, in numerous CA types, 
makes the CA family a serious target for cancer research.  A table outlining some of the 
conditions and cancers associated with carbonic anhydrase follows.  
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CA gene Associated Conditions Associated Cancers 
CA1 
hyperthyroidism, erythroleukemia, thyroid 
diseases (Stelzer, Dalah, Stein, & al, 
2011) 
thyroid
 
(Odcikin, Ozdemir, Ciftci, & al, 
2002); non-small cell lung cancer
 
(Chiang, 
Chu, Yang, & al, 2002); adenocarcinomas 
of prostate, stomach, breast, and ovary
 
(Ozensoy, Kockar, Arslan, & al, 2006);oral 
squamous cell carcinoma (Liu, et al., 
2012) 
CA2 
acidosis renal tubular, osteopetrosis, 
calcification, glaucoma, biliary cirrhosis, 
Sjogrens syndrome, chronic pancreatitis 
(Stelzer, Dalah, Stein, & al, 2011) 
squamous cell carcinoma
 
(Chiang, Chu, 
Yang, & al, 2002);  adenocarcinomas of 
prostate, lung, stomach, breast, and 
ovary (Ozensoy, Kockar, Arslan, & al, 
2006) 
CA3 
reflux, rhabdomyolysis, neuromuscular 
diseases
 (Stelzer, Dalah, Stein, & al, 
2011)   
CA4 
retinitis pigmentosa, glaucoma (Stelzer, 
Dalah, Stein, & al, 2011) 
 
CA8   
non-small cell lung cancer, colorectal 
carcinoma
 (Stelzer, Dalah, Stein, & al, 
2011) 
CA9   
renal clear cell carcinoma (Stelzer, Dalah, 
Stein, & al, 2011);  carcinomas of lung, 
bladder, rectum, colon, uterine cervix, 
and breast, mesothelioma, and brain 
cancer (Masayuki Nakao, 2009) 
(Sherwood, Colquhoun, & D., 2007)
 
(Rasheed, Harris, & Tekkis, 2008)
 
(Liao, 
Darcy, Randall, & al, 2010)
 
(Hsieh, Chen, 
Chiou, & al, 2010)
 
(Kivela, Knuuttila, 
Sihvo, & al, 2012)
 
(Dungwa, Hunt, 
Ramani, & al, 2012) 
CA12   
renal clear cell carcinoma, colorectal and 
breast carcinomas, brain cancer (Stelzer, 
Dalah, Stein, & al, 2011); uterus 
(Hynninen, et al., 2011); oral (Chien, et 
al., 2012) 
CA13  
Colorectal cancer (Kummola, et al., 2005) 
Table 3 - Conditions and cancers associated with each carbonic anhydrase. 
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3. Active Site 
The reversible hydration of CO2, occurring in the active site of carbonic anhydrase, is a two-step 
process.  In the first step, during hydration, zinc-bound water is converted to OH
-
 when His64 
shuttles an H
+
 ion out of the active site into bulk solution.  In the second step the newly 
activated OH
-
 attacks CO2 creating HCO3
-
 (bicarbonate).  Water then replaces bicarbonate which 
is released into bulk solution (Lindskog, 1997) (Fisher, et al., 2007) (Zheng, Avvaru, Tu, & 
Silverman, 2008). 
1) Buffer + His64 + Zn-H2O ↔ Buffer + H
+
-His64 + Zn-OH
-
 ↔ H
+
-Buffer + His64 + Zn-OH
-
 
2) Zn-OH
- 
+ CO2 ↔ Zn-HCO3 + H2O ↔ Zn-H2O + HCO3 
 
Protons leaving and entering the active site are passed through a series of three water 
molecules, commonly called W1, W2, and W3a/W3b, whose position is maintained by 
hydrogen bonding with amino acids lining the active site (Fisher, et al., 2007) (Maupin & Voth, 
2010) (Fisher, et al., 2005).  Furthest from the site of catalysis, and after W2, the water chain 
bifurcates into W3A and W3B.   
The movement of hydrogen into and out of the active site of carbonic anhydrase, for the 
purpose of catalysis, is well established.  However, the method of this movement is not 
perfectly understood and more than one hypothesis of this action exists which are discussed in 
the following sections.  
 
3.1 Proton Shuttle 
3.1.1 Grotthuss Mechanism 
In many experimental papers on carbonic anhydrase, and more commonly, the Grotthuss 
mechanism of proton transfer is assumed to facilitate proton shuttling.  In a paper published in 
1806, German born Theodor Grotthuss 
hypothesized, in French, on the transfer of 
charge through a solution of water by 
conducting experiments with battery and 
solution (Cukierman, 2006).  Grotthuss 
surmised that positive and negative 
properties must both exist within the water 
molecule, and correctly associated the 
charges with H and O.  Despite his 
misunderstanding of the water molecule, in 
his belief that it consisted of a single O and H, 
Figure 4 -  Proton Shuttling in Grotthus Mechanism – Cuckierman “et tu 
grotthuss” (Cukierman, 2006). 
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he envisaged a chain of temporary molecular unions as dissociated charged atoms traveled 
through water towards their respective complementary electrodes (Cukierman, 2006).  The 
understanding of this process has evolved since its first elucidation, and an underlying principle 
has taken shape, that proton shuttling occurs through temporary formation of a Hydronium ion 
passing like a wave through adjacent water molecules in a chain later described a ‘wire’ (Nagle 
& Morowitz, 1978).  Modern interpretation of the Grotthuss mechanism additionally describes 
hydrogen bonding between H and O in sequential waters (Cukierman, 2006).  This wire consists 
of a hydronium and three waters, the composite being called an Eigen cation H3O
+
-(H2O)3 
(Figure 4 row 1) (Cukierman, 2006) (Wraight, 2006) (Riccardi, et al., 2006).  As a free H
+
 bonds 
to the first accepting water (H2O
1
) one of its hydrogen’s, whichever has previously hydrogen-
bonded to O in the next water (H2O
2
), will detach to form the next Hydronium, this process is 
visualized in (Figure 4 row 2).  In the intermediate step, before a H
+
 is passed to the next water, 
a complex known as a Zundel cation H2O-H
+
-OH2 forms (Figure 4 row 2) (Wraight, 2006) 
(Riccardi, et al., 2006).  This process is repeated until the proton has left the final water. At the 
completion of this process the reoriented molecules will need to rotate to the starting position 
in order to accept a new H
+
 (Cukierman, 2006) (Kale, Herfeld, Dai, & Blank, 2012).  
 
3.1.2 Proton Hole Mechanism 
A counter view to the Grotthuss mechanism is the “Proton Hole” mechanism (PH).  In this 
scenario the proton shuttling action begins at the final water of the group which releases an H
+
.  
The OH
-
 proton hole must then be filled by the preceding waters of the wire (Riccardi, et al., 
2006).  In this fashion a proton will move in the same direction as the Grotthuss mechanism 
however the alteration of water moves in opposite direction (receptor to donor).  Additionally, 
this approach accounts for the creation of a wave of negatively, instead of positively, charged 
molecules.  Riccardi et al. propose that the PH mechanism is potentially as commonplace as the 
Grotthuss mechanism.  They assert that, in cases when the final water in a proton shuttling wire 
inhabits a basic environment, energetically, a primary release of H
+
 will be favored (Riccardi, et 
al., 2006).  The opposite is assumed in cases where the final water inhabits an acidic 
environment.  Predictions about the nature of proton shuttling, and in particular that of CAII, 
were generated using a complex model based on both quantum mechanical and molecular 
mechanical (QM/MM) simulations (Riccardi, et al., 2006).  The results showed that the serial 
conversion of water to OH
-
 was favored for the transfer of protons, and that polar residues in 
the active site favorably stabilized OH
-
 (Riccardi, et al., 2006).  While acknowledging the 
significant potential for error in complex simulations the researchers support their supposition 
with a relevant fact.  Owing to the function of CA to interconvert the negatively charged 
bicarbonate, it is likely the active site has evolved to this purpose and therefore favors 
negatively charged molecules. 
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3.1.3 Combination Grotthuss & Proton Hole 
A combinatory explanation of proton transfer was proposed by Kale et al., after simulation 
using their less computationally expensive LEWIS model.  In this scenario the final proton 
receptor, receives H
+
 from the preceding water characteristic of the PH mechanism.  At the 
same time the Hydronium ion at the proton donating end transfers H
+
 to the water in position 
two.  The proton and proton hole travel towards one another until meeting in the middle of the 
water wire (Kale, Herfeld, Dai, & Blank, 2012). 
 
3.2 CA Active Site Amino Acids 
Aside from the internal structure supporting 
amino acids, those that occupy the active site are 
quite understandably some of the most 
important within the whole protein.  It is for this 
reason that a number of these amino acids are 
strongly conserved both among species’ 
orthologs and across isoforms.  In the following 
sections are discussed those active site amino 
acids which have been noted to be of functional 
significance when it comes to catalytic activity of 
the often studied CA-II protein. The majority of 
studies reference the CA-II number system, as a 
result all following references to CA sequence 
position shall be made based on that scale unless 
otherwise noted. 
 
3.2.1 Tyrosine7 
Previous experiments have shown that substitution for Tyr7 has a dramatic effect on proton 
shuttling into and out of the active site while having no effect on de/hydration.  Mikulski et al. 
replaced Tyr7 with seven amino acids (I, A, W, D, N, R, and S) resulting in proton transfer rates 
ranging between 0.8-2.5 μs
-1 
compared to 0.8 μs
-1
 for wild type (Mikulski, et al., 2011).  An even 
more significant gain was achieved with a Y7F replacement, as performed by Fisher et al. 
(Fisher, et al., 2007), resulting in a seven-fold increase in rate at 7 μs
-1
.   
Experiments performed by Fisher et al. tested the effect on proton shuttling ability of 
mutations at the amino acids which maintain the W3a and W3b water molecules, specifically 
Figure 5 - Important amino acids of the wild type HCA-II active site.  
The large central grey sphere represents a zinc atom while the smaller 
red spheres represent water and are thus labeled (W1, W2, W3A, and 
W3B).  The dashed red lines are hydrogen bonds (Mikulski, et al., 2012). 
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Y7F, N62L and N67L (Fisher, et al., 2007).  The previously mentioned proton transfer rate of 7 
μs
-1
, achieved by Y7F replacement, was attributed to three factors: Observed inward 
orientation of His64 side-chain, collapse of the W3a water position, and increased acidity of 
His64 (Fisher, et al., 2007).   
In support of the first supposition, An et al. showed in 2002 that the outward orientation of 
His64 side-chain non-critical for functioning of the proton shuttle (An, et al., 2002).  Rescue of 
catalytically inactive H64A HCA II occurs through addition of proton donor 4-methylimidazole 
(4-MI).  The Trp5 side-chain occupies the ‘out’ position of His64 in HCA II wild-type and is a 
known binding site for 4-MI.  Replacement of Trp5 with residues blocking 4-MI binding did not 
disrupt rescue of the H64A mutant, suggesting that the ‘out’ position does not promote H
+
 
shuttling in HCA II (An, et al., 2002).  Despite the enhanced proton shuttling ability of the Y7F 
mutant the Tyr7 residue is widely conserved among chordates.  The reduced thermo-stability of 
a Y7F protein, by ~4°C and higher in other replacements (Mikulski, et al., 2011), is a potential 
reason for retention of Tyrosine at this position. 
Regarding the second supposition, the bifurcation of the proton shuttling pathway that occurs 
between W2 and W3A/B may result in reduced strength of hydrogen bonding between them. 
This, comparatively, reduced affinity could limit the speed of proton transport at that juncture.  
Supporting this idea is a recent experiment in which a double mutant human CA-II (Y7F and 
N67Q) also observed a collapse of the W3A water position and catalytic activity as high as 9 μs
-1 
(Mikulski, et al., 2012); in this experiment the authors note that a reduced distance between 
elements of the water chain resulted in stronger hydrogen bonds. 
 
3.2.2 Asn62 
The hydrophilic asparagine residue at position 62 plays an important role in both supporting the 
water network and configuration of the His64 side-chain.  Specifically, the Asn62 position 
supports water position W3B as can be seen in Figure 5.  An experiment by Zheng et al. showed 
that site mutations of this Asn amino acid in HCA-II (N62A, N62V, N62L, and N62D) produced a 
CA protein with either predominantly inward or outward oriented His64 side-chain (Zheng, 
Avvaru, Tu, & Silverman, 2008).  Fractional catalytic activity was observed from the one mutant 
(N62D) that produced a majority outward orientation.   
 
3.2.3 Asn67  
The asparagine located at position 67 is also involved in maintenance of the water chain and 
side chain position of His64.  A N67L mutant CA-II, created by Maupin et al., was shown to also 
cause His64 to favor an outward orientation while at the same time disrupting the water 
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network (Maupin, et al., 2009).  Along with Asn62, the Asn67 position supports the water chain 
at position W3B (Figure 6).   
 
3.2.4 His64 
Arguably the most important residue involved in the transfer of protons to and from the active 
site is histidine at position 64.  In wild type human CA-II the His64 amino acid side chain can 
occupy a space between water chain positions W3A and W3B (Figure 5).  From this location it is 
able to receive from, or donate to, either of these entry points to the water chain.   Many 
experiments, both in-vivo and in-silico, have demonstrated the effect that loss or reorientation 
of His64 has on the catalytic activity of CA (primarily CAII) (Zheng, Avvaru, Tu, & Silverman, 
2008) (An, et al., 2002) (Riccardi, et al., 2006) (Mikulski, et al., 2011) (Fisher, et al., 2005) 
(Becker, Klier, Schuler, McKenna, & Deitmer, 2011).  It has not been conclusively demonstrated 
whether or not the imidazole side-chain of His64 needs to be oriented towards the active site, 
the ‘in’ position, or have flexibility to switch between both ‘in’ and ‘out’.  However, experiments 
have shown that when the side-chain is maintained in an outward position the catalytic activity 
of CA drops dramatically (Zheng, Avvaru, Tu, & Silverman, 2008) (Maupin, et al., 2009) (Zheng, 
Avvaru, Tu, & Silverman, 2008).   
 
3.2.5 Thr199 
A threonine at position 199 performs a very significant function and yet is not studied as often 
as other active site residues.  This residue is highly conserved in human CAs present in all 
isoforms except CA-XI.  Located directly next to the zinc in the deepest reaches of the active 
site, this amino acid forms a hydrogen bond with the H2O or OH
-
 which is bound to zinc.  
Previous experiments have shown that substitution at this location for a hydrophobic alanine 
results in a rate of catalysis reduced by a factor of 100 (Liang, Xue, Behravan, Jonsson, & 
Lindskog, 1993).  Additionally, the amine group of the Thr199 position forms a hydrogen bond 
to a water molecule most greatly recessed in the active site, and aptly called the ‘deep water’, 
which the zinc bound water also binds with (Lindskog, 1997).  Owing to its deep location and 
multiple hydrogen bonds, the Thr199 position has been identified as a location where CA 
inhibitors bind (Lindskog, 1997). 
 
3.2.6 Thr200 
Threonine at position 200 is responsible for stabilizing the water chain at position W1 (Figure 
5).  Unlike Thr199 this amino acid is significantly more variable in human CAs and is substituted 
with histidine (CA-I), valine (CA-XIII), and isoleucine (CA-VIII, CA-X).  A 1990 study by Behravan 
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et al. made the assertion that Arg, Val, Ile, or His in this position resulted in activity 
approximating that of CA-I (Behravan, Jonsson, & Lindskog, 1991).  Interestingly, those isoforms 
lacking Thr at this position, including two catalytically inactive CARPs (CA-VIII, CA-X), are those 
with the 2
nd
 and 3
rd
 slowest catalytic rates (CA-XIII, CA-I).   
 
3.3 Tools and Theory 
The entirety of the work performed in this thesis was completed on a laptop based Ubuntu 
Linux installation.  Of the software explained in the following sections some versions are 
available across multiple platforms, in at least some level of functionality, while others are 
currently available only for Linux.   
 
3.3.1 Ensembl 
The Ensembl online database (http://www.ensembl.org) provides both browser-based and 
MySQL server access to genome data for 72 species as of its most current release number 72 
(made available in April 2013).  The species available are primarily chordate and mammalian, 
however a variety of fish and bird species are present as well as a few invertebrates.  Additional 
releases are generally based on the addition of new species to the database and occur roughly 
every 3 months while previous releases remain accessible indefinitely.  Annotated genes are 
easily searched within all, or particular, species.  Homolog relationships are predicted by the 
Compara pipeline which can be used to easily compare both intra and interspecies sequence 
variations.   
Ensembl release number 68 (made available in July 2012) was the primary source of data for 
this thesis as it provided the best compatibility with the PyCogent library for data retrieval 
(discussed in a later section).  The Ensembl database was used to retrieve: protein sequences of 
orthologs, raw genomic data surrounding genes, and expressed sequence tags (EST) associated 
with target genes.  ESTs have been derived from mRNA sequences and are retrieved from the 
UniGene database. 
 
3.3.2 Python 
All scripting created in order to complete this thesis was written using the freely available, open 
source, and dynamic Python programming language (Python.org).  For complete compatibility 
with existing supplementary modules, such as Biopython, Python version 2.7 was used despite 
the existence of the most current version 3.3. 
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3.3.3 Biopython 
The widely used, freely available, and open source Biopython libraries have enabled handling 
of, and performing functions on, DNA and protein sequences within the Python environment 
since 1999 (Cock, et al., 2009).  The Biopython package has a wide array of functionality, and in 
addition to creating simple sequence objects will also: load Multiple Sequence Alignments 
(MSA), query various sequence databases (Entrez, ExPASy, InterPro, KEGG, and SCOP), and 
perform phylogenetic related functions.  For the purposes of this thesis Biopython was used to 
create sequence records and write/handle FASTA sequence files. 
 
3.3.4 PyCogent 
Perhaps the single most import set of libraries involved in this thesis are those described by 
Python the Comparative GENomic Toolkit, or PyCogent.  Similar to Biopython, this library 
toolkit provides a wide variety of bioinformatics tools to be called by the Python programming 
language.  Some of the tools present in this library include: access to a number of online 
databases (NCBI, KEGG, PDB, Rfam, and most notably Ensembl), phylogenetic analysis, and 
sequence alignment (Knight, et al., 2007). 
While supporting a variety of analyses, PyCogent was initially designed to focus on comparative 
analysis of sequences by providing a wealth of tools for retrieving sequences, phylogenetic 
analysis with a variety of models, and visualization.  For the purposes of this thesis PyCogent 
was primarily utilized to query the Ensembl database for orthologs, genomic regions, and ESTs.  
Additionally, the PyCogent phylogenetic tools were utilized to determine relatedness of 
orthologs using the F81 maximum likelihood model. 
 
3.3.5 GeneWise 
The primary use of the GeneWise algorithm is to predict a gene from genomic data using a 
related sequence as a template.  The algorithm is available as a download in the Wise2 
software package at the European Bioinformatics Institute (EBI) 
(www.ebi.ac.uk/Tools/psa/genewise/help/). It is also available for direct use on a number of 
public university webservers and at EBI.  Most importantly, GeneWise is extensively used by the 
Ensembl project to model genes based on homologous sequences in other species.   To predict 
genes by mapping cDNA and EST data to a species genome, the related, and newer, 
Genomewise algorithm is used (Birney, Clamp, & Durbin, 2004).  The GeneWise webserver was 
used in the beginning steps of this thesis work for gene prediction before settling on the more 
robust Exonerate software; it was also the primary software for gene prediction in the 
manuscript serving as a seed for initiation of this thesis (Tolvanen, et al., 2012). 
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GeneWise addresses the gene 
prediction problem, and that of 
alignment, through the utilization of 
Hidden Markov Models (HMM) 
which are statistical methods often 
initially used in speech recognition 
(Rabiner, 1989).  HMMs find their 
root in Markov processes, which 
originated in the 1950’s (Meyer, 
2009).  HMMs can be used to 
predict the likelihood of protein or 
DNA sequence occurring after 
training.  The training of an HMM 
involves analysis of a set of 
sequences, thus allowing for 
derivation of frequencies of 
particular amino acids, or 
dinucleotide bases, at each position 
(Figure 7) (Krogh, 1998).  Similarly, 
when comparing two sequences during an alignment, a probability score is generated.  The 
GeneWise algorithm makes comparisons twice and thus uses two separate HMMs.  The first 
HMM compares the genomic data, which is a sequence of DNA, to the six possible protein 
sequences that can be derived from it (reading frames 1,2,3 in both forward and reverse 
strands).  The second HMM compares these six sequences to the ortholog, or related protein 
sequence, which has been provided as a template for what the gene may look like (Birney, 
Clamp, & Durbin, 2004). 
 
Figure 6 - Diagram of GeneWise6:23 HMM model.  States (6) are represented by both circles and 
rectangles (intron states).  Transitions (23) are represented by arrowed lines (Birney, Clamp, & 
Durbin, 2004). 
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Figure 7 - A) A short segment of MSA used for training an HMM.  B) An HMM trained by the sequences in A.  At each position in the chain, called a state, the 
probability of having each base (A,C,G,T) is noted.  Arrowed lines indicate transitions.  Using this HMM the probability that a new sequence is related to the 
profile can be calculated (Krogh, 1998). 
 
While multiple GeneWise models exist for user choice (GeneWise21:93, GeneWise6:23, 
GeneWise4:21), the default model, and most heavily tested, is GeneWise6:23.  In this model 
there are 6 states and 23 transitions (Figure 6).  
 
3.3.6 Exonerate 
A novel algorithm named Bounded Sparse Dynamic Programming (BSDP) was developed by Guy 
Slater and Ewan Birney of the European Bioinformatics Institute (EBI).  Optimal alignment 
building between two sequences, such as that achieved by Dynamic Programming (DP) in the 
Needleman-Wunsch algorithm is computationally expensive.  Given two sequences of length m 
and n, time complexity for alignment is represented by m x n or if the two sequences are the 
same length m
2
.  This is known as quadratic time (O(m
2
)) (Slater & Birney, 2005).  The objective 
of the algorithm is to reduce time complexity by only calling for the more computationally 
intensive DP alignment method over short distances instead of the full length of two 
sequences.  This algorithm builds High-scoring Segment Pairs (HSP) in the same fashion as the 
traditional Basic Local Alignment Search Tool (BLAST).  Once an HSP has been generated the 
character possessing the median score within an HSP is located.  This location is identified such 
that half the total score of the HSP falls on either side (Slater & Birney, 2005).  In joining HSPs to 
form a continuous alignment a Sub-Alignment Region (SAR) is created as a rectangle whose 
opposing corners are defined by the previously identified median score character (Figure 8).  
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When there are multiple possible combinations of HSPs, an upper score limit, or bound, is 
calculated for each combination.  If a score for an HSP combination is calculated that is higher 
than the upper possibility for the other combinations, a full calculation is not made for the 
remaining possibilities and they are discarded.  This approach dramatically reduces the time 
required for an alignment.  The BSDP approach identifies five possible HSP scenarios and 
defines a specific approach for each.  Most relevant to this thesis work is the connection of 
HSPs on either side of an intron.  In this case the SAR scores are carried from one HSP to the 
next.  Additionally, splice site prediction is built into the algorithm. 
 
 
Figure 8 – BSDP joining of two HSPs.  A Sub-Alignment Region is generated as bounded by the center defined by total score of each HSP.  A DP approach will only 
be applied within this region. (Slater & Birney, 2005) 
 
The Exonerate software package created by Guy Slater and Ewan Birney of EBI implements a 
number of models based on alignment algorithms ranging from simple ungapped alignments of 
protein or DNA sequences to alignment of very large sequences on the scale of whole 
chromosomes, named as follows: 
• ungapped 
• affine 
• est2genome 
• ner 
• protein2dna 
• protein2genome 
• coding2coding 
• cdna2genome 
• genome2genome 
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The specific model utilized in this thesis allows for comparison of a query protein sequence to a 
target genomic sequence (protein2genome).  When Ensembl contained only a partial protein 
record for a CA protein for a certain species the genomic region containing the partial protein 
for that species was compared to the full protein sequence of a closely related species.   
 
3.3.7 Clustal Omega 
In their 2011 paper Sievers et al. extoll the benefits of the algorithms used in their new Clustal 
Omega Multiple Sequence Alignment (MSA) package (Sievers, et al., 2011).  The algorithm 
performs comparably with high quality alignment algorithms when aligning low numbers of 
sequences.  However, Clustal Omega outperforms all other algorithms when large numbers of 
sequences, or particularly long sequences, are aligned.  Furthermore, the package is able to 
operate on nearly indefinite alignment sizes by today’s standards.  Computational complexity 
for an optimal alignment of more than two sequences is defined by O(L
N
) where L is the length 
of sequences and N is the number of sequences (Sievers, et al., 2011).  A time demand of this 
complexity is prohibitive for excessively long or numerous sequences.  Indeed, when 
Needleman and Wunsch first demonstrated their alignment algorithm their paper was limited 
to 10 runs of 5 sequences of length ~150 amino acids due to processing time constraints 
(Needleman & Wunsch, 1970).  Since the development of early, exhaustive alignment 
algorithms a variety of new approaches have been built that greatly increase the speed of 
alignment while attempting to maintain as much of their accuracy as possible.  However, the 
majority of these approaches either cannot handle aligning more than a few thousand 
sequences and/or are not accurate when handling larger alignments.  Sievers et al. state that 
their program has successfully handled up to 190,000 sequences in an alignment performed by 
a single processor in “a few hours” (Sievers, et al., 2011).  While Clustal Omega does not rank 
the highest in quality of alignment it does offer the best ratio of quality and speed and it is for 
this reason that it was used for general MSAs in this thesis. 
 
3.3.8 DSSP 
In 1983, when the number of known protein structures was just over 100, Wolfgang Kabsch and 
Christian Sander described a Dictionary of Protein Secondary Structure (DSSP) (Kabsch & 
Sander, 1983).  The objective of the DSSP was identification of secondary structure from atomic 
coordinates created during x-ray crystallography.  At the time the determination of secondary 
structure (SS) was based on either a subjective manual approach or an algorithm inferior in 
accuracy; Kabsch and Sander decided to base their algorithm on H-bonding patterns (Kabsch & 
Sander, 1983).   In addition to SS, Kabsch and Sander also describe how “solvent exposure” for 
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any residue is calculated based on the number of water molecules (W) that can interact with its 
surface.  Using the following equation: 
W = Area/Volume(water molecule)
2/3
 
This determination becomes very useful when deciding which residues of a protein are 
accessible to the surface and therefore likely play an interacting role with other proteins, 
compounds, or water.  However, an additional step is required after solvent exposure has been 
determined.  In this step the solvent exposure of the residue is divided by the total surface area 
of the specific amino acid, thus deriving the Relative Solvent Accessibility (RSA).  Assignment of 
a protein integrated amino acid to either ‘surface’ or ‘buried’ is based on RSA, however no strict 
guidelines have been set.  Generally an RSA of 0.25 to 0.30 is used to demarcate the boundary 
between these two categories, where a value lower indicates the amino acid is buried inside of 
the protein and a higher value indicates the amino acid is on the surface and accessible for 
interaction.  However, a recent study by Amir Momen-Roknabadi et al. proposes that when 
predicting secondary structure utilizing RSA values, a single threshold for buried/exposed  
assignment does not perform as well as using thresholds unique to each amino acid (Momen-
Roknabadi, Sadeghi, Pezeshk, & Marashi, 2008).  In a 2012 study of 587 yeast genes, Scherrer et 
al. presented their findings that the RSA and conservation of amino acids were linearly related 
(Scherrer, Meyer, & Wilke, 2012).  The relationship highlighted increased conservation of 
residues with low RSA (buried location) and increased variability of residues having a higher RSA 
(surface location). This observation is logical under the premise that residues near the center of 
a protein often perform a structural function, and more greatly impact proper folding, while 
those at the surface do so to a lesser extent.   
Since the publication of the DSSP in 1983 a program has been produced for automated 
processing of PDB files.  The program is available online (http://swift.cmbi.ru.nl/gv/dssp/) and is 
written for use on both Windows and Linux.  Additionally, there are a number of databases 
which contain pre-computed data for all current PDB files as described by (Joosten, et al., 
2010).   
 
3.3.9 PAL2NAL 
The PAL2NAL algorithm is available for use online in its webserver version at the Bork group 
website (http://www.bork.embl.de/pal2nal/), and as downloadable program, coded in Perl, 
which can be utilized on Linux.  The program’s primary function is to take as input both aligned 
protein sequences (Figure 9) and their corresponding unaligned DNA sequences (Figure 10), 
and output codon-aligned DNA sequences (Figure 11); this pair of sequence alignments (codon-
aligned DNA and protein) is essential when computing Ka/Ks values for conservation analysis 
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and for constructing more refined phylogenies (Suyama, Torrents, & Bork, 2006).  A few 
conservation analysis programs that utilize codon alignments are: 
• gKaKs (Zhang, Wang, Long, & Fan, 2013) 
• Selecton (Doron-Faigenboim, Stern, Mayrose, Bacharach, & Pupko, 2005) 
• WSPMaker (Lee, Kim, Kang, Chung, & Shin, 2008) 
• SNAP (HIV Databases, 2013) (Korber, 2000) 
• HyPhy/DataMonkey (Pond, Frost, & Muse, 2005) (Delport, Poon, Frost, & Pond, 2010) 
 
Phylogeny calculating programs which utilize codon alignment are: 
• PAML (Yang, Phylogenetic Analysis by Maximum Likelihood (PAML), 1997) 
• MrBayes (Ronquist, et al., 2011) 
• PhyML (Guindon & Gascuel, 2003) 
 
While a number of programs exist that will make a codon alignment for perfectly translatable 
DNA sequences, PAL2NAL allows for the wholly common discrepancies that can exist between 
DNA and amino acid sequences that purportedly represent the same protein.  The algorithm 
will also account for such features as untranslated regions (UTRs) and polyA tails, which are 
removed in an initial step (Suyama, Torrents, & Bork, 2006).   
Programmatically and algorithmically the PAL2NAL is both simple and clever in its approach.  
The amino acid sequences are converted to regular expression based on the redundancy of the 
codon table; options for both ‘universal’ and ‘vertebrate mitochondria’ are available.  For 
example, a short amino acid sequence MNG would be represented as (A(T|U)G) (AA(T|U|C)) 
(GG.). Frame shifts due to insertion/deletion are easily overcome by changing the regular 
expression pattern to allow for the changed number of bases between two known residues, 
however this is only addressed within coding regions (Suyama, Torrents, & Bork, 2006). 
After codon-alignment of the DNA sequences the PAL2NAL program is itself capable of 
performing a Ka/Ks analysis through calling of codeml program included in the PAML package 
(Yang, Phylogenetic Analysis by Maximum Likelihood (PAML), 1997).  However, the program 
limits the analysis to only two sequences due to the computational complexity of the analysis. 
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Figure 9 – An alignment of protein sequences, at least two, are required as input to begin the codon alignment process within PAL2NAL (Suyama, Torrents, & 
Bork, 2006). 
 
Figure 10 – The corresponding unaligned DNA sequences are additionally required as input where the UTR and Poly-A tails are identified (blue) and removed 
(Suyama, Torrents, & Bork, 2006). 
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Figure 11 - The final output of the PAL2NAL program are the codon aligned DNA sequences (Suyama, Torrents, & Bork, 2006).   
 
3.3.10 Selecton 
The Selecton algorithm is available both on a webserver located at (http://selecton.tau.ac.il/) or 
as a download for both Windows and Linux.  Taking as input codon aligned DNA sequences, the 
Selecton webserver will perform a Ka/Ks analysis, generate a conservation score from 1-7 
(where higher indicates greater conservation), and map these scores onto the residues of a 3-D 
model of the target protein if one is available (Figure 12).  Additionally, a linear figure can be 
produced showing graded conservation (Figure 12), which is especially useful if no model has 
been determined for the target protein.  The downloadable version produces output files 
necessary to produce these outputs but it must be done manually. 
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Figure 12 – At left, a linear figure created by Selecton webserver, depicting results of Ka/Ks conservation analysis of a 493 amino acid protein.  Ka/Ks values have 
been grouped to 7 categories (1-7) and each amino site colored accordingly to allow visual identification of regions of continuous positive or negative selection 
(Stern, et al., 2007).  At right, 3D model produced by Selecton webserver.   The protein sequences are analyzed for Ka/Ks values which are then mapped onto 
each amino acid in the protein.  Ka/Ks values were divided into 7 categories each of which was assigned a color
(Doron-Faigenboim, Stern, Mayrose, Bacharach, & Pupko, 2005) (Selecton, 2013).
 
3.3.10.1 Ka/Ks 
While the Selecton program produces excellent images and models for understanding 
conservation within groups of homologous proteins, these are simply tools for interpreting the 
core output, which are Ka/Ks values (identified as ω).  In this type of conservation analysis, Ka 
indicates the incidence of asynonymous mutation (where the subscript ‘a’ stands for 
asynonymous).  In a codon where the three bases TTT would result in phenylalanine, and a 
mutation changes the third base to ‘A’ (TTA), the mutation is asynonymous as the new codon 
would now present a leucine.  On the other hand, if mutation changes the third base to a ‘C’ 
(TTC), the redundancy of the codon table allows that this too will code for phenylalanine and as 
such the mutation is considered synonymous.  Assuming that mutation events are essentially 
random, we would predict that if no selection was occurring then synonymous and 
asynonymous mutations would occur at equal frequency (when adjusting for the redundancy of 
the codon table).  As a result, an amino acid site with a Ka/Ks ratio that is higher than 1 has more 
mutation than expected by chance, which is considered evidence for positive selection.  On the 
other hand an amino acid site with a Ka/Ks ratio that is less than 1 has less mutation than 
expected by chance, which is considered evidence for ‘purifying selection’ (Stern, et al., 2007).  
The seeds for Ka/Ks analysis were first sown by Kimura in 1968 when he proposed the Neutral 
Theory (Kimura, Evolutionary Rate at the Molecular Level, 1968).  Counter to prevailing strictly 
Darwinian Theory of evolution at the time, the Neutral Theory proposed that the majority of 
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evolutionary change occurred as a result of random neutral mutations which can be fixed by 
random genetic drift (Kimura, The neutral theory of molecular evolution: A review of recent 
evidence, 1991).  The Neutral Theory can easily exist alongside Darwinian Theory, at least in the 
mind of its author, and simply explains the more common, if less dramatic, evolutionary 
changes that life experiences.   
The Selecton program determines ω at each site in a query sequence (e.g. Human CAII) by 
comparing codon-aligned DNA sequences of homologous proteins (e.g. Human CAII orthologs).  
The Selecton webserver documentation notes a requirement of 3 sequences with at least 10 
being recommended for significant results (Selecton, 2013). 
 
3.3.10.2 Codon Evolutionary Models 
Evolutionary models whose resolution only extends to the level of amino acids can only reliably 
describe conservation.  The benefit of determining these areas of conservation is that it allows 
identification of what residues might be of most significance within a protein.  These residues 
might be involved in protein-protein interaction, ligand-binding, or be of structural significance.  
Conversely, residues and regions that are more actively mutated are regions of interest as well 
for some, but not all, of the same reasons.  While a more variable residue is detrimental to 
internal structure, it can be useful for interacting with other proteins.  The example query 
protein presented in (Stern, et al., 2007) is TRIM5α which, owing to an identified region of 
increased variability, is thought to confer resistance to HIV-1 in rhesus monkey cells.  The 
benefit of extending evolutionary models to incorporate codon data, and determining ω, is that 
not only can conservation be determined in a more precise manner but also variation can be 
measured (Doron-Faigenboim & Pupko, A Combined Empirical and Mechanistic Codon Model, 
2006).  As there are 3 nucleotide positions per codon, and 4 possible nucleotides per position, 
the total number of possible codons is 4
3
, or 64. When discounting the three stop codons, there 
are 61 possible codon substitutions that can be considered; in one of the first codon models of 
evolution, by Goldman and Yang in 1994, this 61x61 matrix came into use (Zoller & Schneider, 
2010).  In this early model and those that have come since, a series of parameters are 
considered to be important to properly build the substitution matrix.  Thus, the models have 
become known as ‘parametric models’.  The parameters commonly introduced in a number of 
these models are (Zoller & Schneider, 2010): 
• ω – Ka/Ks ratio 
• π – Codon frequencies 
• K – Relative rates of transition/tranversion 
• V – Physical and chemical distances 
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The objective of parametric models was to emulate real world frequencies of substitution as 
closely as possible.  In 2005 the first empirical model was created by Schneider et al. by making 
use of the recently widely expanded sequenced vertebrate genomic data available at Ensembl 
(Zoller & Schneider, 2010) (Schneider, Cannarozzi, & Gonnet, 2005).  However, while this new 
method was an improvement over many parametric methods, the authors recognized that it 
was just starting point, and that additional analysis of specific sets of sequences could produce 
better models (Schneider, Cannarozzi, & Gonnet, 2005).  In 2006, Doron-Faigenboim and Pupko 
created a codon model that was a hybrid of the parametric approach and empirical data; 
termed the Mechanistic Empirical Codon model (MEC), it is discussed more thoroughly in the 
next section (Doron-Faigenboim & Pupko, A Combined Empirical and Mechanistic Codon 
Model, 2006).  In 2007, Kosiol et al. claimed their Empirical Codon Model (ECM) was the first 
empirical model, despite the existence of the 2005 model produced by Schneider et al.  The 
primary difference touted by Kosiol et al. is the consideration of codon substitutions resulting 
from double and triple simultaneous mutations, instead of just single changes (Kosiol, Holmes, 
& Goldman, 2007).   
 
Table 4 - Codon models for conservation analysis. 
Model Author Type Year 
Codon-based Model of Nucleotide Substitution 
(Goldman & Yang, 1994) 
Goldman and Yang Parametric 1994 
A Likelihood Approach for Comparing 
Synonymous and Nonsynonymous Nucleotide 
Substitution Rates (Muse & Gaut, 1994) 
Muse and Gaut Parametric 1994 
Continuous Positive-Selection (Nielsen & Yang, 
1998) 
Nielsen and Yang Parametric 1998 
M0-M13 (Yang, Nielsen, Goldman, & Pedersen, 
Codon-Substitution Models for Heterogeneous 
Selection Pressure at Amino Acid Sites, 2000) 
Yang et al. Parametric 2000 
Branch-Site (Yang & Nielsen, Codon-
Substitution Models for Detecting Molecular 
Adaptation at Individual Sites Along Specific 
Lineages, 2002) 
Yang and Nielsen Parametric 2002 
Fixed-Site (Yang & Swanson, Codon-
Substitution Models to Detect Adaptive 
Evolution that Account for Heterogeneous 
Selective Pressures Among Site Classes, 2002) 
Yang and Swanson Parametric 2002 
Empirical Codon (E) (Schneider, Cannarozzi, & 
Gonnet, 2005) 
Schneider et. al Empirical 2005 
Mechanistic Empirical Codon (MEC) (Doron-
Faigenboim & Pupko, A Combined Empirical 
and Mechanistic Codon Model, 2006) 
Doron-Faigenboim and 
Pupko 
Parametric+Empirical 2006 
Empirical Codon Model (ECM) (Kosiol, Holmes, 
& Goldman, 2007) 
Kosiol, Holmes, and 
Goldman 
Empirical 2007 
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Selecton provides a number of options of evolutionary models for determination of Ka/Ks values 
(M5, M7, M8, M8a, and MEC).  While the earlier strictly mechanistic models provide a less 
computationally intensive approach the results are also less accurate.  It is for this reason that 
the MEC model was used. 
The MEC model is the only codon model utilizing an empirical component available in the 
Selecton program, and was the only model used in this thesis research.  In order to combine the 
strength of empirical codon models with that of parametric (mechanical) models, the MEC 
model uses three different empirical data sets.  The first is the JTT data matrix so named for its 
creators Jones, Taylor, and Thornton which was compiled in 1992 from all proteins longer than 
20 peptides within SWISS-PROT Release 15.0 (Jones, Taylor, & Thornton, 1992).  The second is 
mtREV, which was derived from mitochondrial genes of 20 vertebrate species by Adachi et al. 
(Adachi & Hasegawa, 1996).  Finally is cpREV, which was compiled from chloroplast containing 
organisms such as algae, diatom, plants etc. (Adachi, Waddell, & Hasegawa, 2000).  Like the 
ECM model, the MEC model takes into account the possibility for substitutions at more than 
one codon position simultaneously (Doron-Faigenboim & Pupko, A Combined Empirical and 
Mechanistic Codon Model, 2006).  The following equation describes the basis on which codon 
substitution values are weighted within the MEC model: 
 
ψi = Frequency of amino acid i in empirical dataset (e.g. JTT matrix) 
Aij = Substitution rate of amino acid i to amino acid j 
Σ {l:aaI = i} = Number of codons coding for amino acid i 
Σ{s:aas = j} = Number of codons coding for amino acid j 
πl = Frequency of codon l 
Q
*
ls = Substitution rate of codon l to codon s, accounting for any combination of transition or 
transversion across all three base positions within the codon. 
 
Coupling the determined codon frequency with transition/transversion bias allows for a 
determination of likelihood of codon substitution.  Within this equation are visible the two 
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elements that make this a combined Mechanistic and Empirical codon model.  On the left side 
ψi and Aij rely on previously defined large empirical datasets of protein/nucleotide sequences.  
On the right side πl and Q
*
ls take into account codon frequencies and transitions/transversions 
to set mechanistic parameters from the target sequences.  In the case of the MEC model these 
parameters are estimated using maximum likelihood, a statistical method for estimating 
parameters of a larger population from a subset of it, derived by R. A. Fisher in 1922 (Aldrich, 
1997).   
In their paper (Doron-Faigenboim & Pupko, A Combined Empirical and Mechanistic Codon 
Model, 2006), Doron-Faigenboim and Pupko compare their MEC model with M8 (Yang, Nielsen, 
Goldman, & Pedersen, Codon-Substitution Models for Heterogeneous Selection Pressure at 
Amino Acid Sites, 2000), M5 (Yang, Nielsen, Goldman, & Pedersen, Codon-Substitution Models 
for Heterogeneous Selection Pressure at Amino Acid Sites, 2000), and E (Schneider, Cannarozzi, 
& Gonnet, 2005) codon models using 13 data sets including nuclear, mitochondrial, chloroplast, 
and viral sequences.  The MEC model outperformed the other models in 11 of the 13 sets, and 
scored relatively near the top model in the other two. 
 
3.3.11 Chimera 
Chimera is a molecular visualization software program produced by the University of California 
at San Francisco (UCSF); it is written primarily in Python and available for Windows, Linux, Mac 
OS X and other operating systems (Petterson, et al., 2004).  Chimera accepts PDB files as input 
and possesses a variety of visualization options for displaying a protein in a simulation of three 
dimensions as depicted in Figure 13.  In this thesis, script files (.cmd) controlling the Chimera 
software were automatically generated from Python scripts in order to create publication-
quality images.  
 
Figure 13 - PDB model 3FE4 for Human Carbonic Anhydrase VI, as visualized in Chimera.  The image on the left is the initial view of pdb entry 3FE4, a dimer of CA-
VI, and the image on the right is the same protein, as a monomer, after being altered via a Chimera script to highlight conservation. 
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4. Research Goals 
The overall goal of this research is development of a pipeline for conservation analysis of a 
target multi-species protein.  This goal is accomplished through a number of smaller tasks 
including: 
• Automated retrieval of Ensembl orthologs and identification of incomplete protein 
sequences. 
• Manual annotation and correction of incomplete sequences through gene prediction 
and homology analysis. 
• Ka/Ks conservation analysis, using the MEC codon model, resulting in generation of 
figures and 3D models highlighting contrasting conservation by individual residue.   
The created pipeline should then be used to identify areas of positive and negative selection on 
the now expanded complete carbonic anhydrase IV orthologs.  Through comparative analysis of 
varying branches of life it is the intention of this research to also identify amino acids and 
regions of interest that are unique, and functionally significant, to each.  From this analysis it 
may be possible to provoke hypotheses about the structure and function of CAs and generate 
targets for future research. 
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5. Methods 
5.1 Scripts 
All scripts were created using Python in the Linux environment.  In the following sections each 
script of major importance has been reduced to pseudo-code for readability.   
 
5.1.1 Orthologer 
The ‘Orthologer’ script was the most complex work created during this thesis research.  The 
final version contains approximately 600 lines of python code, uses 20+ python modules, 
connects to the Ensembl database, and calls 6 external bioinformatics programs to process 
data. 
For each human α-CA gene in Ensembl: 
 Create output files for protein, CDS, and Complete sequences 
 Retrieve all orthologs from Ensembl (1to1, 1tomany, manytomany) 
 Write protein and CDS sequences for each ortholog to files 
Create a distance table from a phylogeny based on F81 model from all sequences 
Set INCOMPLETE = orthologs with protein sequences with lengths more than 5% longer 
or shorter than average for that CA gene 
 
For each ortholog in INCOMPLETE: 
Extract genomic sequence for ortholog from Ensembl, with additional 50% of 
length of gene added to each end 
Set NEIGHBOR = closest related Complete protein sequence from distance table 
Call Exonerate program to make prediction of gene from genomic sequence using 
NEIGHBOR as template 
If any ESTs for ortholog: 
Call Exonerate program to make prediction of gene from EST sequence(s) 
using NEIGHBOR as template 
Create file containing ORTHOLOG, NEIGHBOR, and EST protein sequences 
Call Clustal Omega to create alignment and output file 
  
 
5.1.2 SEQs2Categories 
The purpose of the ‘SEQs2Categories.py’ script is to create categorized FASTA files from all 
complete sequences retrieved, or derived, from Ensembl. Five categories of organisms 
35 
 
(vertebrates, invertebrates, fishes, birds, and mammals) are separated so that each can have 
Ka/Ks analysis completed independently to identify unique areas of conservation.  Immediately 
preceding the use of this script is the only truly manual step in this created conservation 
analysis pipeline.  In the manual step, protein sequences that have been predicted by Exonerate 
are compared in an alignment. The sequences determined to be good predictions are added to 
a FASTA file containing all complete protein sequences, while the same is done for the 
corresponding CDS sequences.  This file is the primary input for this script.  In advance of 
completion of this script, all species within the Ensembl database were individually placed into 
17 distinct lists which were then referenced by this script. 
Open FASTA files of complete protein and CDS sequences 
For each category (vertebrates, invertebrates, fishes, birds, and mammals): 
 Create protein and CDS output file 
 For each specie entry in protein FASTA file: 
  Write specie entry to output file if contained in category list  
 For each specie entry in CDS FASTA file: 
  Write specie entry to output file if contained in category list 
 
5.1.3 Unaligned2KaKs 
The primary task of this script is to call the Ka/Ks program to complete conservation analysis on 
any of the category FASTA files created by the previous script.  However, these files must first 
be codon aligned therefore Clustal Omega and Pal2Nal are called. 
Open protein and CDS FASTA files 
For each specie entry CDS FASTA file: 
 If entry contains ‘homo sapiens’ set KaKsQueryid to entry’s id 
Call Clustal Omega to create alignment file from protein FASTA file 
Call Pal2Nal to create codon alignment file from aligned protein FASTA file and unaligned CDS 
FASTA file 
Set Selecton parameters 
Call Selecton to create conservation analysis from codon aligned file and KaKsQueryid using 
defined parameters 
 
5.1.4 RESparser – Histo+Line 
First of the scripts designed to produce easily interpreted visuals from the raw Ka/Ks data 
produced by the Selecton program; the output of this script is a colored histogram of the Ka/Ks 
values associated to each amino acid.  A line graph of the data is also produced. 
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Open .res file 
Parse entries for each amino acid 
Set list ySeries = 1/(Exracted Ka/Ks values) 
Set list xSeries = Extracted amino acid # 
Give each amino acid, for both .res files, a score of 1-7 based on Ka/Ks value 
Create colored histogram, and separate linegraph, across all amino acids based on level of 
conservation 
 
5.1.5 RESparser – Histo Compare 
The objective of this script is to compare two .res conservation files of two different groups of 
species.  In the resulting histogram variations in conservation values become easily identified, 
and the residue type and number easily obtained. 
Open .res files 
Parse entries for each amino acid of both files 
Set list ySeries = 1/(Exracted Ka/Ks values) 
Set list xSeries = Extracted amino acid # 
Give each amino acid, for the primary .res file, a score of 1-7 based on Ka/Ks value 
Assign a unique color to each level of conservation 
For the primary .res amino acids create a colored histogram across all amino acids based on 
level of conservation 
For the secondary .res amino acids underlay a thinner black colored bar 
 
5.1.6 RESparser – PDB 
These final two scripts also provide automated visualization of the conservation analysis.  They 
take as input a single Ka/Ks analysis .res file that is output by the Selecton program, and a PDB 
file. One of seven colors is mapped onto each amino acid, in the PDB model, that is not 
disordered with coloration based on level of conservation. 
Query for .res file 
Open .res file 
Parse entries for each amino acid 
Set list ySeries = 1/(Exracted Ka/Ks values) 
Set list xSeries = Extracted amino acid # 
Query for PDB model number, and model chain 
Call DSSP program to extract DSSP data from full PDB model 
Create new PDB file containing only the protein chain specified by user 
Call DSSP program to extract DSSP data from single chain PDB model 
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Determine relative solvent accessibility (RSA) for each amino acid  
Align protein sequence derived from PDB DSSP data with Ensembl sequence within .res file 
Correlate Ensembl protein amino acid numbering with PDB protein model numbering 
Give each amino acid a score of 1-7 based on Ka/Ks value 
 Assign a unique color to each level of conservation 
Create .cmd output file for chimera with each amino acid colored 
 
5.1.7 RESparser – PDB – Compare 
This final, and most complex, visualization script takes as input two .res files of taxa between 
which a comparison should be made.  The Ka/Ks values at each residue are compared and those 
which vary by a significant amount are marked for coloration in the resulting Chimera .cmd file. 
Query for .res files to be compared 
Open .res file 
Parse entries for each amino acid 
Set list ySeries = 1/(Exracted Ka/Ks values) 
Set list xSeries = Extracted amino acid # 
Query for PDB model number, and model chain 
Call DSSP program to extract DSSP data from full PDB model 
Create new PDB file containing only the protein chain specified by user 
Call DSSP program to extract DSSP data from single chain PDB model 
Determine relative solvent accessibility (RSA) for each amino acid  
Align protein sequence derived from PDB DSSP data with Ensembl sequence within .res file 
Correlate Ensembl protein amino acid numbering with PDB protein model numbering 
Give each amino acid, for both .res files, a score of 1-7 based on Ka/Ks value 
Compare each amino acid to equivalent in other .res file 
 Identify those sites where the score differs by 3 or more 
Create .cmd output file for chimera with amino acids colored either red or blue if the site in the 
first .res file is 3 or more levels greater or if the amino acid in the second .res file is 3 or more 
levels greater, respectively. 
 
5.2 Manual Analysis 
Three criteria were used to identify an ‘Incomplete’ sequence for the orthologs proteins 
retrieved from the Ensembl database: 
1. Lack of initiating methionine ‘M’. 
2. Presence of ‘X’ in sequence; this indicates Ensembl homology prediction of sequence 
length but lack of supporting sequence data. 
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3. Length of sequence less than 95% of human sequence. 
 
For each incomplete protein an alignment was created, using Clustal Omega, from the 
incomplete protein, Exonerate prediction from extragenomic data, and Exonerate prediction 
for EST data.  Manual analysis of this alignment, in many cases, resulted in corrected or more 
complete sequences.   
 
 
Figure 14 - A) Alignment of incomplete protein Takifugu rubripes CA-II, and protein predicted from T. rubripes extragenomic data using Danio rerio CAH-Z.  B) 
Partial segment of alignment of all CA-II orthologs.  Based on the Exonerate prediction and supporting evidence from the alignment, the beginning of the 
predicted sequence is taken as accurate and the corresponding portion of the Ensembl sequence is discarded. 
 
Further work will be completed to conservatively automate as much of this manual analysis as 
possible, however this endeavor is beyond the scope of this thesis. 
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6. Results 
6.1 Manual Analysis 
The orthologer script extracted 32 complete and 33 incomplete orthologs, to human CA-IV, 
from the Ensembl database.  Manual analysis of the incomplete orthologs resulted in 
modification of 7 of the sequences.  A total of 79 amino acid changes were made to the 7 
sequences, by either removal or addition.  Another 7 sequences were sufficiently long to merit 
inclusion into the complete group, for a total of 46 complete proteins.  The final collection of 
complete CA-IV proteins for Ka/Ks analysis included the following numbers of proteins within 
respective groupings: 33 vertebrates, 13 invertebrates, 17 mammals, 13 fishes, 2 birds, 1 lizard.  
An extended study was made through manual analysis of the cytoplasmic CAs (I, II, III, VII, and 
XIII).  In these five isozyme groups, there were 90 proteins determined to be incomplete.  An 
additional 420 residue changes were made among 50 of these proteins.
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CA1 >ENSCPOG00000012870 Cavia_porcellus-CA1 x       x     Removed 'I' Complete 261 260 1 
CA1 >ENSGACG00000014774 Gasterosteus_aculeatus-CA1 x       x     Removed “AGQRTAAAA” Complete 269 260 9 
CA1 >ENSGGOG00000008746 Gorilla_gorilla-CA1 x x           NO CHANGE Complete 257 257 0 
CA1 >ENSMICG00000000860 Microcebus_murinus-CA1 x x x       x NO CHANGE INCOMPLETE 183 183 0 
CA1 >ENSOPRG00000014213 Ochotona_princeps-CA1 x x           Added exonerate supported anterior “G” Complete 247 248 1 
CA1 >ENSOCUG00000005039 Oryctolagus_cuniculus-CA1         x     NO CHANGE INCOMPLETE 227 227 0 
CA1 >ENSORLG00000008342 Oryzias_latipes-CA1 x             NO CHANGE Complete 266 266 0 
CA1 >ENSPMAG00000008967 Petromyzon_marinus-CA1 x     x       NO CHANGE Complete 261 261 0 
CA1 >ENSSARG00000001803 Sorex_araneus-CA1         x     NO CHANGE INCOMPLETE 241 241 0 
CA1 >ENSTRUG00000008077 Takifugu_rubripes-CA1 x     x x     
Replace anterior “IHILMFMLILTQNYTQFLYSYCTNTHRKPRNYLTIR” with 
“MSHTWGYGPSNGP” INCOMPLETE 261 222 39 
CA1 >ENSTSYG00000006199 Tarsius_syrichta-CA1 x x           Added exonerate supported anterior “G” Complete 248 249 1 
CA1 >ENSTNIG00000006037 Tetraodon_nigroviridis-CA1       x       Removed anterior  “AG” Complete 260 258 2 
CA1 >ENSTBEG00000004632 Tupaia_belangeri-CA1         x   x NO CHANGE INCOMPLETE 223 223 0 
CA2 >ENSACAG00000009431 Anolis_carolinensis-CA2 x     x       Removed anterior “FT” Complete 259 257 2 
CA2 >ENSBTAG00000017733 Bos_taurus-CA2 x x           NO CHANGE Complete 249 249 0 
CA2 >ENSCJAG00000000351 Callithrix_jacchus-CA2 x     x       Removed anterior “AT” Complete 262 260 2 
CA2 >ENSCHOG00000000722 Choloepus_hoffmanni-CA2 x x x         NO CHANGE INCOMPLETE 182 182 0 
CA2 >ENSECAG00000016228 Equus_caballus-CA2 x     x       Removed anterior “T” Complete 261 260 1 
CA2 >ENSFCAG00000005137 Felis_catus-CA2 x x           Added exonerate supported anterior “G” Complete 248 249 1 
CA2 >ENSGACG00000014774 Gasterosteus_aculeatus-CA2 x     x       Removed anterior “AGQRTAAAA” Complete 269 260 9 
CA2 >ENSMODG00000025608 Monodelphis_domestica-CA2 x             NO CHANGE Complete 264 264 0 
CA2 >ENSMODG00000015855 Monodelphis_domestica-CA2 x     x       Removed anterior “TFRSAVQSTTEKLKDFKN” Complete 282 254 28 
CA2 >ENSMLUG00000022410 Myotis_lucifugus-CA2 x             NEEDS REVIEW NEEDS REVIEW 266 266 0 
CA2 >ENSOANG00000002036 Ornithorhynchus_anatinus-CA2 x x           NEEDS REVIEW NEEDS REVIEW 259 259 0 
CA2 >ENSORLG00000008342 Oryzias_latipes-CA2 x             Removed anterior “KVVYDSFPFGQESVS” Complete 266 251 15 
CA2 >ENSPMAG00000008967 Petromyzon_marinus-CA2 x             Added anterior exonerate supported “K” Complete 261 262 1 
CA2 >ENSPVAG00000002689 Pteropus_vampyrus-CA2 x x           Added exonerate supported anterior “HKG” Complete 248 251 3 
CA2 >ENSSARG00000001849 Sorex_araneus-CA2 x x x         NO CHANGE INCOMPLETE 182 182 0 
CA2 >ENSSSCG00000006140 Sus_scrofa-CA2 x             Removed anterior “TT” Complete 262 260 2 
CA2 >ENSTGUG00000011728 Taeniopygia_guttata-CA2 x             Removed anterior “T” Complete 261 260 1 
CA2 >ENSTRUG00000008077 Takifugu_rubripes-CA2 x             NEEDS REVIEW NEEDS REVIEW 247 247 0 
CA2 >ENSTNIG00000006037 Tetraodon_nigroviridis-CA2 x             Removed anterior "AN" Complete 260 258 2 
CA2 >ENSTBEG00000010555 Tupaia_belangeri-CA2         x     NO CHANGE INCOMPLETE 220 220 0 
  
  
                  
    
  
CA3 >ENSACAG00000024792 Anolis_carolinensis-CA3 x             NO CHANGE Complete 248 248 0 
CA3 >ENSDORG00000001002 Dipodomys_ordii-CA3             x NO CHANGE INCOMPLETE 260 264 4 
CA3 >ENSETEG00000007613 Echinops_telfairi-CA3             x NO CHANGE INCOMPLETE 260 260 0 
CA3 >ENSEEUG00000007144 Erinaceus_europaeus-CA3         x     NO CHANGE INCOMPLETE 221 221 0 
CA3 >ENSFCAG00000008051 Felis_catus-CA3         x   x NO CHANGE INCOMPLETE 219 219 0 
CA3 >ENSGALG00000019454 Gallus_gallus-CA3 x     x       Removed anterior “GTGAPCRRSRGELRCRAERST” Complete 283 262 21 
CA3 >ENSGACG00000014774 Gasterosteus_aculeatus-CA3 x     x       Removed anterior “AGQRTAAAA” Complete 269 260 9 
CA3 >ENSGGOG00000010673 Gorilla_gorilla-CA3 x     x       Removed anterior “T” Complete 262 261 1 
CA3 >ENSLAFG00000004404 Loxodonta_africana-CA3 x     x x     Removed anterior “T”.  Added Posterior “K”. Complete 260 260 2 
CA3 >ENSMEUG00000000900 Macropus_eugenii-CA3 x   x         NO CHANGE Complete 248 248 0 
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CA3 >ENSMLUG00000016286 Myotis_lucifugus-CA3 x   x         Removed anterior “ELTSLSG” INCOMPLETE 192 185 7 
CA3 >ENSOANG00000002034 Ornithorhynchus_anatinus-CA3 x     x       Removed anterior “AGRQGIPEERAGGQSRSRRPRDGERRSRGRKEI”. Complete 293 260 33 
CA3 >ENSORLG00000008342 Oryzias_latipes-CA3 x             Removed anterior “KVVYDSFPFGQESVS”. Complete 266 251 15 
CA3 >ENSPMAG00000008967 Petromyzon_marinus-CA3 x             Removed anterior “LSSRIEDNDDRA” Complete 261 249 12 
CA3 >ENSPVAG00000007169 Pteropus_vampyrus-CA3             x NO CHANGE INCOMPLETE 258 258 0 
CA3 >ENSTGUG00000018183 Taeniopygia_guttata-CA3 x             NO CHANGE Complete 258 258 0 
CA3 >ENSTRUG00000008077 Takifugu_rubripes-CA3 x     x x     
Replaced anterior “IHILMFMLILTQNYTQFLYSYCTNTHRKPRNYLTIR” with 
“MSHTWGYGPSNG” INCOMPLETE 247 226 21 
CA3 >ENSTSYG00000010505 Tarsius_syrichta-CA3         x     Added “RSLFASAENEPPVPLVGNWRPP” intron. Complete 238 260 22 
CA3 >ENSTNIG00000006037 Tetraodon_nigroviridis-CA3 x     x       Removed anterior “AN” Complete 261 259 2 
CA3 >ENSTTRG00000005803 Tursiops_truncatus-CA3 x   x         NO CHANGE Complete 248 248 0 
CA3 >ENSVPAG00000003347 Vicugna_pacos-CA3 x   x         NO CHANGE Complete 248 248 0 
  
  
                  
    
  
CA4 >ENSACAG00000015167 Anolis_carolinensis-CA4 x x           NO CHANGE Complete 318 318 0 
CA4 >K05G3.3 Caenorhabditis_elegans-CA4     x   x     NO CHANGE Complete 246 246 0 
CA4 >ENSCJAG00000001097 Callithrix_jacchus-CA4             x NO CHANGE NEEDS REVIEW 256 256 0 
CA4 >ENSCING00000010731 Ciona_intestinalis-CA4         X     NO CHANGE NEEDS REVIEW 258 258 0 
CA4 >ENSDNOG00000010140 Dasypus_novemcinctus-CA4 x           x Removed anterior “GR” INCOMPLETE 311 309 2 
CA4 >ENSDORG00000007143 Dipodomys_ordii-CA4 x x     X     NO CHANGE INCOMPLETE 225 225 0 
CA4 >FBgn0039235 Drosophila_melanogaster-CA4         x     NO CHANGE Complete 279 279 0 
CA4 >FBgn0040628 Drosophila_melanogaster-CA4         x     NO CHANGE Complete 284 284 0 
CA4 >ENSETEG00000017554 Echinops_telfairi-CA4 x x x         NO CHANGE INCOMPLETE 218 218 0 
CA4 >ENSEEUG00000013445 Erinaceus_europaeus-CA4 x x x   x     NO CHANGE INCOMPLETE 208 208 0 
CA4 >ENSGACG00000020471 Gasterosteus_aculeatus-CA4 x x     x     NO CHANGE INCOMPLETE 282 282 0 
CA4 >ENSGACG00000011230 Gasterosteus_aculeatus-CA4 x             NO CHANGE Complete 317 317 0 
CA4 >ENSMICG00000013382 Microcebus_murinus-CA4 x           x NO CHANGE INCOMPLETE 313 313 0 
CA4 >ENSMODG00000014115 Monodelphis_domestica-CA4 x x x   x     NO CHANGE INCOMPLETE 225 225 0 
CA4 >ENSMODG00000003392 Monodelphis_domestica-CA4 x x           NO CHANGE Complete 292 292 0 
CA4 >ENSMLUG00000024982 Myotis_lucifugus-CA4 x             NEEDS REVIEW INCOMPLETE 302 302 0 
CA4 >ENSOPRG00000017181 Ochotona_princeps-CA4 x x x         NO CHANGE INCOMPLETE 270 270 0 
CA4 >ENSOANG00000004545 Ornithorhynchus_anatinus-CA4 x       x     NO CHANGE INCOMPLETE 286 286 0 
CA4 >ENSOCUG00000009399 Oryctolagus_cuniculus-CA4 x             NO CHANGE Complete 293 293 0 
CA4 >ENSORLG00000002507 Oryzias_latipes-CA4 x             NO CHANGE Complete 309 309 0 
CA4 >ENSPCAG00000005108 Procavia_capensis-CA4             x NO CHANGE INCOMPLETE 306 306 0 
CA4 >ENSTRUG00000012774 Takifugu_rubripes-CA4 x             NO CHANGE Complete 316 316 0 
CA4 >ENSTRUG00000006382 Takifugu_rubripes-CA4 x             Removed anterior “APLPQTLTANFDVTFISTLK” Complete 304 284 20 
CA4 >ENSTRUG00000007204 Takifugu_rubripes-CA4 x             Removed anterior “RSILPSTL” Complete 311 303 8 
CA4 >ENSTRUG00000007249 Takifugu_rubripes-CA4 x             Removed anterior “TL” Complete 313 311 2 
CA4 >ENSTNIG00000008558 Tetraodon_nigroviridis-CA4         x     Added posterior “GKPMVGTFRPVQPLNGRQVFHSGAAAALTSSA” Complete 260 292 32 
CA4 >ENSTNIG00000016135 Tetraodon_nigroviridis-CA4 x             NO CHANGE Complete 309 309 0 
CA4 >ENSTBEG00000014112 Tupaia_belangeri-CA4             x NO CHANGE INCOMPLETE 311 311 0 
CA4 >ENSTTRG00000008780 Tursiops_truncatus-CA4 x           x Added anterior “MPIAGTPEEVGLG” INCOMPLETE 290 304 14 
CA4 >ENSVPAG00000009703 Vicugna_pacos-CA4 x x x         Added anterior “V” INCOMPLETE 219 220 1 
CA4 >ENSXETG00000013489 Xenopus_tropicalis-CA4 x       x     NO CHANGE INCOMPLETE 282 282 0 
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CA7 >ENSCPOG00000024957 Cavia_porcellus-CA7 x             Removed anterior “SSG” Complete 264 261 3 
CA7 >ENSDNOG00000019175 Dasypus_novemcinctus-CA7 x   x       x NO CHANGE INCOMPLETE 263 263 0 
CA7 >ENSDORG00000013532 Dipodomys_ordii-CA7               NO CHANGE Complete 250 250 0 
CA7 >ENSETEG00000011874 Echinops_telfairi-CA7             x NO CHANGE INCOMPLETE 263 263 0 
CA7 >ENSECAG00000024943 Equus_caballus-CA7 x             Added anterior “GHHGLGAYQNDGPSEWHKLYPIAQ” Complete 238 262 24 
CA7 >ENSEEUG00000011058 Erinaceus_europaeus-CA7 x   x         Added anterior “TV” INCOMPLETE 184 186 2 
CA7 >ENSFCAG00000012773 Felis_catus-CA7 x   x       x NO CHANGE INCOMPLETE 250 250 0 
CA7 >ENSMEUG00000007011 Macropus_eugenii-CA7         x     NO CHANGE INCOMPLETE 224 224 0 
CA7 >ENSOANG00000012209 Ornithorhynchus_anatinus-CA7 x   x         NO CHANGE Complete 250 250 0 
CA7 >ENSPVAG00000000385 Pteropus_vampyrus-CA7             x NO CHANGE INCOMPLETE 262 262 0 
CA7 >ENSSARG00000011702 Sorex_araneus-CA7 x   x         NO CHANGE INCOMPLETE 224 224 0 
CA7 >ENSSSCG00000022094 Sus_scrofa-CA7             x 
Replaced anterior intron of “APXSDERSHSYFSGERQRRPPITNQYRIQPSCVLTX” 
with “GPSXXXXXXXXXXGDRQSPINIVSSQAVYSPSLKPL”. INCOMPLETE 269 269 36 
CA7 >ENSTSYG00000001353 Tarsius_syrichta-CA7 x   x         NO CHANGE INCOMPLETE 183 183 0 
CA7 >ENSTNIG00000009424 Tetraodon_nigroviridis-CA7 x     x       Removed anterior “GK” Complete 263 261 2 
CA7 >ENSTBEG00000010634 Tupaia_belangeri-CA7 x   x         NO CHANGE INCOMPLETE 177 177 0 
  
  
                  
    
  
CA13 >ENSACAG00000014147 Anolis_carolinensis-CA13 x             Removed anterior “PA” Complete 262 260 2 
CA13 >ENSDORG00000004299 Dipodomys_ordii-CA13 x   x         NO CHANGE Complete 250 250 0 
CA13 >ENSETEG00000015776 Echinops_telfairi-CA13 x   x       x Added anterior “G” INCOMPLETE 250 251 1 
CA13 >ENSECAG00000013368 Equus_caballus-CA13 x             NO CHANGE Complete 251 251 0 
CA13 >ENSEEUG00000014581 Erinaceus_europaeus-CA13 x           x Added anterior “G” INCOMPLETE 250 251 1 
CA13 >ENSFCAG00000008686 Felis_catus-CA13             x NO CHANGE INCOMPLETE 263 263 0 
CA13 >ENSGALG00000015820 Gallus_gallus-CA13 x             Removed anterior “A” Complete 260 259 1 
CA13 >ENSGACG00000014774 Gasterosteus_aculeatus-CA13 x     x       Removed anterior “AGQRTAAAA” Complete 269 260 9 
CA13 >ENSMEUG00000002395 Macropus_eugenii-CA13 x       x   x NO CHANGE INCOMPLETE 210 210 0 
CA13 >ENSMLUG00000006164 Myotis_lucifugus-CA13 x             NO CHANGE Complete 263 263 0 
CA13 >ENSOPRG00000014191 Ochotona_princeps-CA13             x NO CHANGE INCOMPLETE 257 257 0 
CA13 >ENSOANG00000002031 Ornithorhynchus_anatinus-CA13 x             Removed anterior “YSELGWGFL” Complete 259 250 9 
CA13 >ENSORLG00000008342 Oryzias_latipes-CA13 x             Removed anterior “KVVYDSFPFGQESVS”. Complete 266 251 15 
CA13 >ENSPMAG00000008967 Petromyzon_marinus-CA13 x             Removed anterior “LSSRIEDNDDRA”.  Added posterior “K”. Complete 261 250 13 
CA13 >ENSPVAG00000005236 Pteropus_vampyrus-CA13 x             Added anterior “G” Complete 250 251 1 
CA13 >ENSTGUG00000011722 Taeniopygia_guttata-CA13 x             Removed anterior “A” Complete 259 258 1 
CA13 >ENSTRUG00000008077 Takifugu_rubripes-CA13 x       x     
Removed anterior 
“IHILMFMLILTQNYTQFLYSYCTNTHRKPRNYLTIRPDKWAKDFPIADGSRQSPINIVPM 
EAQYDPSLKPLKLNYNQSNAKGILNNGHSFQVLGENKSA”, replaced with 
“MSHTWGYGPSNGPDKWAKDFPIADGSRQSPINIVPM 
EAQYDPSLKPLKLNYNQSNAKGILNNGHSFQVDFVDDADSST” INCOMPLETE 247 222 25 
CA13 >ENSTSYG00000008066 Tarsius_syrichta-CA13         x     NO CHANGE INCOMPLETE 223 223 0 
CA13 >ENSTNIG00000006037 Tetraodon_nigroviridis-CA13 x             Removed anterior “AN” Complete 260 258 2 
CA13 >ENSTBEG00000004374 Tupaia_belangeri-CA13             x NO CHANGE INCOMPLETE 262 262 0 
CA13 >ENSVPAG00000003345 Vicugna_pacos-CA13             x NO CHANGE INCOMPLETE 264 264 0 
CA13 >ENSXETG00000026010 Xenopus_tropicalis-CA13               Removed anterior “TSNM” Complete 266 262 4 
                          499 
Table 5 - Manual changes made to CA-I, CA-II, CA-III, CA-IV, CA-VII and CA-XIII proteins identified as 'incomplete' by Orthologer script.  Changes were based on evidence from protein sequences predicted from genomic and EST data. 
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6.2 Histograms 
After manual gene annotation was performed and a Selecton Ka/Ks analysis performed on the 
resulting updated orthologs, figures were created using data parsed from the Selecton (.res) 
results file.  There are four scripts which parse the .res file containing Ka/Ks analysis and 
produce varying types of output. The RESparser-histo script is responsible for creating 
histograms depicting the inverse of Ka/Ks values at each amino acid position.  As lower Ka/Ks 
values indicate greater conservation the inverse value is used for greater ease of interpretation 
in graphic depictions.  Histograms were created for Ka/Ks analysis of all CA-IV orthologs (Figures 
15-19).   
If the RESparser-histo-compare script is provided with two Selecton results files, for example 
conservation analysis files for both mammal and non-mammal species, the script will produce a 
histogram where the conservation value for each group at each position is superimposed for 
comparison.  The results from the comparison of mammals/non-mammals are included as 
Figures 20-24.   
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Figure 15 – Histogram of Ka/Ks values for residues 1-75 of all complete CA-IV sequences.  Created using Python (Python.org) and Matplotlib (Hunter, 2007). 
 
 
Figure 16 - Histogram of Ka/Ks values for residues 76-150 of all complete CA-IV sequences.  Created using Python (Python.org) and Matplotlib (Hunter, 2007). 
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Figure 17 - Histogram of Ka/Ks values for residues 151-225 of all complete CA-IV sequences.  Created using Python (Python.org) and Matplotlib (Hunter, 2007). 
 
 
Figure 18 - Histogram of Ka/Ks values for residues 226-300 of all complete CA-IV sequences.  Created using Python (Python.org) and Matplotlib (Hunter, 2007). 
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Figure 19 - Histogram of Ka/Ks values for residues 301-312 of all complete CA-IV sequences.  Created using Python (Python.org) and Matplotlib (Hunter, 2007). 
 
 
Figure 20 - Histogram of compared Ka/Ks values, for complete CA-IV sequences from mammals (thick bars) and non-mammals (thin bars), across residues 1-75.  Created using Python 
(Python.org) and Matplotlib (Hunter, 2007). 
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Figure 21 - Histogram of compared Ka/Ks values, for complete CA-IV sequences from mammals (thick bars) and non-mammals (thin bars), across residues 76-150.  Created using Python 
(Python.org) and Matplotlib (Hunter, 2007). 
 
 
Figure 22 - Histogram of compared Ka/Ks values, for complete CA-IV sequences from mammals (thick bars) and non-mammals (thin bars), across residues 151-225.  Created using Python 
(Python.org) and Matplotlib (Hunter, 2007). 
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Figure 23 - Histogram of compared Ka/Ks values, for complete CA-IV sequences from mammals (thick bars) and non-mammals (thin bars), across residues 226-300.  Created using Python 
(Python.org) and Matplotlib (Hunter, 2007). 
 
 
Figure 24 - Histogram of compared Ka/Ks values, for complete CA-IV sequences from mammals (thick bars) and non-mammals (thin bars), across residues 301-312.  Created using Python 
(Python.org) and Matplotlib (Hunter, 2007).
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6.3 3D Protein Models 
The results of the RESparser-PDB script are seen in the depiction of CA-IV conservation in 
mammal and non-mammal groups in Figure 25.  Two different view types are produced 
(columns), each with 3 different orientations (rows) produced by 120 degree rotations around 
the y-axis.  The first view, ‘protein specific’ (column 1 (from left to right) for mammals and 
column 3 for non-mammals), depicts a coloration scheme showing degree of conservation for 
each amino in comparison to other amino acids within the protein.  The second view, ‘selecton’ 
(column 2 for mammals and column 4 for non-mammals) is based on the Selecton model which 
has predetermined values for levels of conservation which are static and independent of which 
protein is being studied.  The output of REparser-PDB-compare is seen in the farthest right 
column, in which 3 views of a 3D model were created comparing mammal and non-mammal 
species conservation values.  There were 17 residues identified as having a conservation level 
score difference of 3 or higher between the two groups.  These residues which were more 
conserved in mammals were Asp183 and Ser227 (marked as red).  The residues more conserved 
in non-mammals were Asn32, Thr35, His64, His94, Lys103, Glu112, His119, Val121, Ala134, 
Ala142, Ser197, Thr199, Lys233, Leu251, and Val256 (marked as blue).  Those most likely 
contributing to structure of the protein are those which have a RSA less than .20, qualifying as 
‘buried’ (His94, His119, Val121, Ala142, Ser197, Thr199, ), while those with an RSA greater than, 
or equal to, .20 qualifying as ‘surface’ (Asn32, Thr35, His64, Lys103, Glu112, Ala134, Asp183, 
Ser227, Lys233, Leu251, Val256). There are some previously identified residues strongly 
correlated with the active site and catalytic activity, such as His64, Thr199, His94, and His 199; 
the remaining residues are previously unidentified as of significant value in the CA proteins, in 
general or to mammal or non-mammal groups. 
The same analysis was performed for vertebrates and invertebrates and the results visualized in 
Figure 26.  In this comparison the following amino acids were considerably more conserved in 
vertebrates: Trp5, Cys6, Gln10, Ala11, Cys23, Ser29, Thr35, Leu44, Asn61, Ala90, Ser105, 
His107, Met116, Leu144, Phe146, Arg193, Ser197, Thr199, Gln222, and Arg246.  Those amino 
acids considerably more conserved in invertebrates: Ile31, Val143, and Thr200. 
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Figure 25 – Panel showing mammal (columns 1,2) and non-mammal (columns 3,4) Ka/Ks conservation mapped onto PDB model 3FW3 Chain B (Vernier, et al., 2010).  In the protein specific models (columns 1,3) the colors are determined by taking 
the top conservation score for the whole protein and dividing by 7.  Scores for each amino acid are colored according to which of the seven levels they fall within with 1 being the least conserved and 7 the most conserved.  This provides an 
understanding of which amino acids are most important within this protein alone.  In the Selecton specific models (columns 2,4) the colors are based on the Selecton model where yellow/orange colors represent positive selection, near white colors 
represent mostly neutral selection, and increasingly intense red colors represent conservation.  The scores resulting in the Selecton color scheme are more general thus providing a comparison of conservation to all proteins.  In column 5 is a 
comparison of mammals and non-mammals.  Amino acids which are significantly more conserved in mammals are marked in red, while those significantly more conserved in non-mammals are marked in blue. 
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Figure 26 - Panel showing vertebrate (columns 1,2) and invertebrate (columns 3,4) Ka/Ks conservation mapped onto PDB model 3FW3 Chain B (Vernier, et al., 2010).  In the protein specific models (columns 1,3) the colors are determined by taking 
the top conservation score for the whole protein and dividing by 7.  Scores for each amino acid are colored according to which of the seven levels they fall within with 1 being the least conserved and 7 the most conserved.  This provides an 
understanding of which amino acids are most important within this protein alone.  In the Selecton specific models (columns 2,4) the colors are based on the Selecton model where yellow/orange colors represent positive selection, near white colors 
represent mostly neutral selection, and increasingly intense red colors represent conservation.  The scores resulting in the Selecton color scheme are more general thus providing a comparison of conservation to all proteins.  In column 5 is a 
comparison of mammals and non-mammals.  Amino acids which are significantly more conserved in vertebrates are marked in red, while those significantly more conserved in invertebrates are marked in blue. 
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7. Discussion 
If the utilization of tools can be regarded a hallmark of intelligence in animals, what conclusions 
can we make about the cell’s use of proteins?  Whether the function regards DNA replication, 
cell maintenance, or disabling pathogens there are certainly proteins involved.  While the 
beginnings of life on earth could function without the wide variety of proteins available to 
modern organisms, attempting to build and maintain a modern cell without them is analogous 
to building a modern computer from raw materials and with no tools. 
Understanding a protein’s structure and function is largely advanced through identification of 
amino acids which have been conserved.  As is evident on the larger scale of physical attributes 
of the body, conservation of an unimportant feature is evolutionarily costly; therefore, only 
those attributes of value are conserved.  An experimental approach to determining the 
importance of a particular amino acid is to use site specific mutation to create a protein altered 
at that single point.  However, this process can take time, especially when considering a 
complete analysis of a whole protein which may possess many hundreds of amino acids.  A 
conservation analysis approach thus saves significant time in the analysis of proteins.  At the 
very least it allows for protein specific identification of subsets of amino acids that could then 
be addressed experimentally.  At best, analysis of a large numbers of proteins can quickly 
identify recurring amino acids critical to structure and function. 
 
7.1 Analysis of Output 
7.1.1 Sequences 
The process created in this thesis work suggests 499 residue changes in 123 carbonic anhydrase 
proteins (groups CA-I, CA-II, CA-III, CA-IV, CA-VII, CA-XIII), and identified 17 key amino acid 
residues that vary most significantly between mammal and non-mammal vertebrates.  A total 
of 23 such amino acid residues were found to differ between vertebrates and invertebrates.    
The approach can be applied to any protein which exists within the Ensembl database and has a 
sufficient number of identified orthologs.  Comparisons can be easily made among any number 
of pairs created from predefined or custom groupings (mammals, fishes, birds, in/vertebrates, 
etc.) by creation of a histogram or 3D model provided there is a PDB structure available.   
7.1.2 Models 
A comparison made in this study highlighted a region of high conservation in non-mammal 
groups not as strongly conserved in mammals.  The residues comprising this region are Asn32, 
Thr35, Lys103, Glu112, Leu251, and Val256.  A previous study of N-glycosylation sites in CA 
isoforms IV, XV, and XVII, showed the same region uniquely devoid of the N-glycosylation motif 
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(Tolvanen, et al., 2012).    Tolvanen et al. proposes that this region is likely devoid of N-
glycosylation in order to allow binding with an ion channel (Tolvanen, et al., 2012).  If this 
supposition is correct, then the differences between mammal and non-mammal CA-IV, in this 
region, could be explained by the fact that mammal ion channel genes differ significantly from 
those in fish (Jegla, Zmasek, Batalov, & Nayak, 2009), and coevolution of each taxon’s CA-IV and 
distinctive ion transporter resulted in a different mode of binding.  In humans, the anion 
exchange 1 (AE1) protein has been suggested to bind to CA-IV (Sterling, Alvarez, & Casey, 2002); 
this research proposes that CA-IV binds with extracellular loop 4 of AE1 while cytoplasmic CA-II 
binds with AE1 on the internal surface of the cell membrane.  AE1 matches tissue expression of 
CA-IV closely, with a presence in erythrocytes, kidney, retina, and heart (Sterling, Alvarez, & 
Casey, 2002) (Wu, et al., 2009).  BioGPS Microarray data analysis of AE1 shows strongest 
expression in early erythrocytes, and while there is significant expression in fetal lung, there is 
not in mature lung (Wu, et al., 2009).  Future research regarding CA-IV ion channel binding 
should focus on the identified residues as potential binding points for AE1.  
 
7.2 Sources of Error 
There are sources of error, inherent to this approach, which are not present in experimental 
approaches.  Perhaps most significant are the errors introduced by an incorrect alignment.  In 
this thesis work an alignment of 46 CA-IV sequences was created, each sequence comprised of 
approximately 300 amino acids.  Any misalignments, at any of the 300 positions, result in an 
altered score of conservation.  However, given the similarity of these sequences, and the 
similarity inherent in any group of true orthologs, this concern is reduced. 
In building the alignments for Ka/Ks analysis, a target sequence must be included to serve as the 
template which Ka/Ks values for the whole alignment are mapped onto.  With the goal of 
mapping two distinct taxa onto single protein, and making a one to one comparison, the target 
sequence for all Ka/Ks analyses was human CA-IV.  This in turn requires that human CA-IV be 
included in the alignment for each of the taxa being compared, even if it was not a part of that 
taxon (e.g. non-mammals, fishes, and invertebrates).  Subsequently, the Ka/Ks analysis for that 
taxon becomes partially ‘contaminated’ by the presence of the human sequence.  A potential 
solution for this would be Ka/Ks analysis of each pure taxon with choice of target sequence 
going to the two sequences most similar between the two taxa.  After analysis, the target 
sequences, and their associated conservation values, could be aligned together.  A PDB protein 
sequence would need to be included into the alignment to allow for display of results on its 
structure. 
An issue related to alignment, is the mapping of conservation values onto a protein which is 
potentially not part of the taxa being analyzed.  The PDB model 3FW3 chain B of human CA-IV 
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was used for all visualizations.  Thus, generating a 3D model for non-mammal or invertebrate 
conservation using 3WF3 as a scaffold is not going to provide as good a presentation of protein 
configuration as mapping those values onto a species more representative of that group.  
However, for consistency, and making 1 to 1 comparisons, the same model is used. 
Another source of error is the conservation analysis.  While it appears that the MEC model is 
the most comprehensive and accurate of all codon models, by definition these models are only 
attempting to approximate the rates of substitution that occur in the natural world; at the very 
least some level of inaccuracy is expected.  Yet there is still much to be gleaned from even the 
broad strokes painted by this method.  Codons representing stronger signals of conservation 
present important opportunities for prediction of protein function and interaction. 
 
7.3 Future Research 
A primary goal of this thesis work was automation of a process to produce visualization of 
protein conservation.  The majority of the steps were translated to python scripting.  However, 
the gene annotation step remained strictly manual.  A significant number of times, analysis of 
predicted sequence alignments proved challenging. Therefore, creation and utilization of a 
strict set of rules would prove beneficial here.  This final step of automation would open up 
much larger venues of analysis.  However, there are a significant number of possible alignment 
and prediction scenarios to account for.  In this attempt it would likely be beneficial to use a 
combined empirical and mechanistic approach similar in concept to the chosen MEC codon 
model.  Analysis of the deficiencies of the sequence targeted will provide the parameters for its 
attempted repair, while the alignment of all good orthologs will provide the empirical data for 
comparison. 
Larger scale analysis of many proteins within a family (e.g. all CA proteins), or similarly folded 
proteins, could provide insight as to which amino acids are most often present at critical fold 
points, provide interaction with other proteins, or are necessary for catalytic activity. 
Perhaps most obviously, the comparative analyses that this pipeline produces can help to 
uncover the activity of proteins whose function is only partially known, or only known in one 
species; distinct differences in conservation allude to a modified purpose specific to that 
organism.  The CA family is a perfect target for this approach as it exists in many forms, both 
catalytically active and inactive, across many varied species.  In the case of disease, 
identification of conserved amino acids and regions is important for the creation of inhibitors or 
treatments.  Where these regions differ between species is important to notice when using 
animal models to test treatment methods. 
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8. Conclusions 
The goal of this thesis was to create a pipeline for analysis of the carbonic anhydrase protein 
family with particular emphasis on CA-IV.  With the aid of the tools developed it is now possible 
to start with an Ensembl protein id and subsequently: retrieve all orthologs, make predictions 
for incomplete orthologs, derive conservation values across all amino acid sites for complete 
sequences, compare conservation among different taxa, produce a 3D model highlighting 
conservation values, and produce publication-quality images.  Through utilization of this 
pipeline it was possible to identify a number of CA-IV amino acids uniquely important within 
different taxa.  
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Appendix A 
 
 
Figure 27 – CA1 expression by tissue (Wu, et al., 2009). 
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Figure 28 – CA2 expression by tissue (Wu, et al., 2009). 
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Figure 29 – CA3 expression by tissue (Wu, et al., 2009). 
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Figure 30 – CA4 expression by tissue (Wu, et al., 2009). 
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Figure 31 – CA5a expression by tissue (Wu, et al., 2009). 
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Figure 32 – CA5b expression by tissue (Wu, et al., 2009). 
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Figure 33 – CA6 expression by tissue (Wu, et al., 2009). 
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Figure 34 – CA7 expression by tissue (Wu, et al., 2009). 
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Figure 35 – CA8 expression by tissue (Wu, et al., 2009). 
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Figure 36 – CA9 expression by tissue (Wu, et al., 2009). 
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Figure 37 – CA10 expression by tissue (Wu, et al., 2009). 
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Figure 38 – CA11 expression by tissue (Wu, et al., 2009). 
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Figure 39 – CA12 expression by tissue (Wu, et al., 2009). 
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Figure 40 – CA14 expression by tissue (Wu, et al., 2009).
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Appendix B 
 
 
 
  
Table 6 – At top, a MUSCLE (Edgar, 2004) based alignment of the catalytic domain of carbonic anhydrases (I, II, III, IV, V, VI, VIII, IX, XIII, XIV) as retrieved from PDB (Bernstein, et al., 1977) entries (2NMX.A (Srivastava, 2007), 2EU2.A (Fisher S. e., 
2006), 3UYQ.A (Elder & al., 2007), 1ZNC.A (Stams & al., 1996), 1KEQ.A (Jude & al., 2002), 3FE4.B (Pilka & al.), 2W2J.A (Picaud & al., 2009), 3IAI.A (Alterio & al., 2009), 1JD0.A (Whittington & al., 2001), 3D0N.A (Di Fiore & al., 2009), 1RJ5.A 
(Whittington & al., 2004)).  RSA of CA-IV amino acids are presented as a line graph.  At middle, secondary structure data created using DSSP is displayed in alignment for all CAs present; helices are shown as red tubes, sheets are green arrows, and 
bends as blue arrows.  Image is presented as created in Jalview, using annotations generated using DSSP and python scripting. 
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1 M - - NA NA   73 S S 50 0.2 Surface   145 K K 124 0.3 Surface   
2 R - - NA NA   74 G G 50 0.2 Surface   146 E E 125 0.64 Surface   
3 M - - NA NA   75 Y Y 51 0.01 Buried   147 K - - NA NA   
4 L - - NA NA   76 D D 52 0.72 Surface   148 G - - NA NA   
5 L - - NA NA   77 K K 53 0.38 Surface   149 T - - NA NA   
6 A - - NA NA   78 K K 54 0.48 Surface   150 S - - NA NA   
7 L - - NA NA   79 Q Q 55 0.22 Surface   151 R - - NA NA   
8 L - - NA NA   80 T T 56 0.63 Surface   152 N - - NA NA   
9 A - - NA NA   81 W W 57 0.01 Buried   153 V - - NA NA   
10 L - - NA NA   82 T T 58 0.3 Surface   154 K - - NA NA   
11 S - - NA NA   83 V V 59 0.01 Buried   155 E E 133 0.8 Surface   
12 A - - NA NA   84 Q Q 60 0.26 Surface   156 A A 134 1.03 Surface   
13 A - - NA NA   85 N N 61 0.01 Buried   157 Q Q 135 0.34 Surface   
14 R - - NA NA   86 N N 62 0.36 Surface   158 D D 136 0.47 Surface   
15 P - - NA NA   87 G G 63 0.13 Buried   159 P P 137 0.63 Surface   
16 S - - NA NA   88 H H 64 0.27 Surface   160 E E 138 0.39 Surface   
17 A - - NA NA   89 S S 65 0.04 Buried   161 D D 139 0.1 Buried   
18 S - - NA NA   90 V V 66 0.01 Buried   162 E E 140 0.23 Surface   
19 A - - NA NA   91 M M 67 0.12 Buried   163 I I 141 0.09 Buried   
20 E - - NA NA   92 M M 68 0.01 Buried   164 A A 142 0 Buried   
21 S - - NA NA   93 L L 69 0.26 Surface   165 V V 143 0.04 Buried   
22 H H 4 1.07 Surface   94 L L 70 0 Buried   166 L L 144 0 Buried   
23 W W 5 0.24 Surface   95 E E 71 0.48 Surface   167 A A 145 0 Buried   
24 C C 6 0.01 Buried   96 N N 72 0.47 Surface   168 F F 146 0 Buried   
25 Y Y 7 0.01 Buried   97 K K 76 0.48 Surface   169 L L 147 0 Buried   
26 E E 8 0.43 Surface   98 A A 77 0.04 Buried   170 V V 148 0 Buried   
27 V V 9 0.27 Surface   99 S S 78 0.2 Buried   171 E E 149 0.35 Surface   
28 Q Q 10 0.11 Buried   100 I I 79 0.01 Buried   172 A A 150 0.5 Surface   
29 A A 11 0.51 Surface   101 S S 80 0.35 Surface   173 G G 151 1.02 Surface   
30 E E 11 0.51 Surface   102 G G 81 0.3 Surface   174 T T 151 1.02 Surface   
31 S S 11 0.51 Surface   103 G G 82 0 Buried   175 Q Q 152 0.34 Surface   
32 S S 11 0.51 Surface   104 G G 83 0.49 Surface   176 V V 153 0.43 Surface   
33 N N 11 0.51 Surface   105 L L 84 0.11 Buried   177 N N 154 0.24 Surface   
34 Y Y 11 0.51 Surface   106 P P 85 0.72 Surface   178 E E 155 0.71 Surface   
35 P P 11 0.51 Surface   107 A A 86 0.25 Surface   179 G G 156 0.19 Buried   
36 C C 11 0.51 Surface   108 P P 87 0.39 Surface   180 F F 157 0 Buried   
37 L L 11 0.51 Surface   109 Y Y 88 0 Buried   181 Q Q 158 0.21 Surface   
38 V V 12 0.2 Surface   110 Q Q 89 0.27 Surface   182 P P 159 0.16 Buried   
39 P P 13 0.07 Buried   111 A A 90 0 Buried   183 L L 160 0.01 Buried   
40 V V 14 0.82 Surface   112 K K 91 0.36 Surface   184 V V 161 0.06 Buried   
41 K K 15 0.73 Surface   113 Q Q 92 0.21 Surface   185 E E 162 0.54 Surface   
42 W W 16 0.01 Buried   114 L L 93 0.01 Buried   186 A A 163 0.07 Buried   
43 G G 20 0.52 Surface   115 H H 94 0.15 Buried   187 L L 164 0 Buried   
44 G G 21 0.79 Surface   116 L L 95 0.01 Buried   188 S S 165 0.53 Surface   
45 N N 22 0.39 Surface   117 H H 96 0.01 Buried   189 N N 166 0.57 Surface   
46 C C 23 0 Buried   118 W W 97 0 Buried   190 I I 167 0 Buried   
47 Q Q 24 0.6 Surface   119 S S 98 0.01 Buried   191 P P 168 0.17 Buried   
48 K K 25 0.35 Surface   120 D D 99 0.31 Surface   192 K K 169 0.34 Surface   
49 D D 26 0.87 Surface   121 L L 100 0.4 Surface   193 P P 170 0.18 Buried   
50 R R 27 0.29 Surface   122 P P 101 0.57 Surface   194 E E 171 0.91 Surface   
51 Q Q 28 0.01 Buried   123 Y Y 102 0.64 Surface   195 M M 172 0.31 Surface   
52 S S 29 0 Buried   124 K K 103 0.42 Surface   196 S S 173 0.47 Surface   
53 P P 30 0 Buried   125 G G 104 0 Buried   197 T T 174 0.18 Buried   
54 I I 31 0.01 Buried   126 S S 105 0 Buried   198 T T 175 0.61 Surface   
55 N N 32 0.36 Surface   127 E E 106 0.01 Buried   199 M M 176 0.01 Buried   
56 I I 33 0.01 Buried   128 H H 107 0 Buried   200 A A 177 0.55 Surface   
57 V V 34 0.37 Surface   129 S S 108 0.01 Buried   201 E E 178 0.69 Surface   
58 T T 35 0.2 Surface   130 L L 109 0.1 Buried   202 S S 179 0.01 Buried   
59 T T 36 0.85 Surface   131 D D 110 0.5 Surface   203 S S 180 0.03 Buried   
60 K K 37 0.82 Surface   132 G G 111 0.54 Surface   204 L L 181 0 Buried   
61 A A 38 0.05 Buried   133 E E 112 0.36 Surface   205 L L 182 0.3 Surface   
62 K K 39 0.39 Surface   134 H H 113 0.38 Surface   206 D D 183 0.28 Surface   
63 V V 40 0.64 Surface   135 F F 114 0.15 Buried   207 L L 184 0.01 Buried   
64 D D 41 0.34 Surface   136 A A 115 0.06 Buried   208 L L 185 0.1 Buried   
65 K K 42 0.55 Surface   137 M M 116 0 Buried   209 P P 186 0.15 Buried   
66 K K 43 0.65 Surface   138 E E 117 0 Buried   210 K K 187 0.44 Surface   
67 L L 44 0.07 Buried   139 M M 118 0 Buried   211 E E 187 0.44 Surface   
68 G G 45 0.43 Surface   140 H H 119 0.01 Buried   212 E E 187 0.44 Surface   
69 R R 46 0.52 Surface   141 I I 120 0.01 Buried   213 K K 188 0.21 Surface   
70 F F 47 0.03 Buried   142 V V 121 0.13 Buried   214 L L 189 0.27 Surface   
71 F F 48 0.54 Surface   143 H H 122 0.01 Buried   215 R R 189 0.27 Surface   
72 F F 49 0.2 Surface   144 E E 123 0.38 Surface   216 H H 190 0.47 Surface   
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217 Y Y 191 0.01 Buried   289 R - - NA NA   
218 F F 192 0.03 Buried   290 P - - NA NA   
219 R R 193 0.07 Buried   291 L - - NA NA   
220 Y Y 194 0.02 Buried   292 P - - NA NA   
221 L L 195 0.35 Surface   293 W - - NA NA   
222 G G 196 0.06 Buried   294 A - - NA NA   
223 S S 197 0 Buried   295 L - - NA NA   
224 L L 198 0.26 Surface   296 P - - NA NA   
225 T T 199 0.06 Buried   297 A - - NA NA   
226 T T 200 0.27 Surface   298 L - - NA NA   
227 P P 201 0.24 Surface   299 L - - NA NA   
228 T T 202 0.53 Surface   300 G - - NA NA   
229 C C 203 0 Buried   301 P - - NA NA   
230 D D 204 0.26 Surface   302 M - - NA NA   
231 E E 205 0.26 Surface   303 L - - NA NA   
232 K K 206 0.2 Surface   304 A - - NA NA   
233 V V 207 0 Buried   305 C - - NA NA   
234 V V 208 0.06 Buried   306 L - - NA NA   
235 W W 209 0.02 Buried   307 L - - NA NA   
236 T T 210 0.01 Buried   308 A - - NA NA   
237 V V 211 0 Buried   309 G - - NA NA   
238 F F 212 0 Buried   310 F - - NA NA   
239 R R 213 0.51 Surface   311 L - - NA NA   
240 E E 214 0.41 Surface   312 R - - NA NA   
241 P P 215 0.19 Buried   
      
  
242 I I 216 0.03 Buried     
243 Q Q 217 0.51 Surface     
244 L L 218 0 Buried     
245 H H 219 0.33 Surface     
246 R R 220 0.58 Surface     
247 E E 221 0.36 Surface   
      
  
248 Q Q 222 0.02 Buried     
249 I I 223 0.08 Buried     
250 L L 224 0.16 Buried     
251 A A 225 0.06 Buried     
252 F F 226 0 Buried     
253 S S 227 0.66 Surface   
      
  
254 Q Q 227 0.66 Surface     
255 K K 228 0.29 Surface     
256 L L 229 0 Buried     
257 Y Y 230 0.28 Surface     
258 Y Y 231 0.05 Buried     
259 D D 232 0.16 Buried   
      
  
260 K K 233 0.39 Surface     
261 E E 236 0.73 Surface     
262 Q Q 237 0.36 Surface     
263 T T 238 0.73 Surface     
264 V V 239 0.11 Buried     
265 S S 240 0.37 Surface   
      
  
266 M M 241 0 Buried     
267 K K 242 0.28 Surface     
268 D D 243 0.13 Buried     
269 N N 244 0 Buried     
270 V V 245 0.23 Surface     
271 R R 246 0.02 Buried   
      
  
272 P P 247 0.46 Surface     
273 L L 248 0.4 Surface     
274 Q Q 249 0.24 Surface     
275 Q Q 250 0.81 Surface     
276 L L 251 0.34 Surface     
277 G G 252 0.6 Surface   
      
  
278 Q Q 253 0.94 Surface     
279 R R 254 0.06 Buried     
280 T T 255 0.75 Surface     
281 V V 256 0.08 Buried     
282 I I 257 0.25 Surface     
283 K K 258 0.25 Surface   
      
  
284 S S 259 0.27 Surface     
285 G - - NA NA     
286 A - - NA NA     
287 P - - NA NA     
288 G - - NA NA     
Table 7 - Alignment of Ensembl entry ENSG00000167434 (Flicek, Amode, Barrell, & al., 2012) CA-IV protein sequence (ENS) with PDB entry 3FW3 (Bernstein, et al., 1977) (Vernier, et al., 
2010) chain B protein sequence (PDB).  Associated RSA values as determined by DSSP (Kabsch & Sander, 1983).  The alignment allows for the association of Ensembl sequence amino acid 
position Ka/Ks values to be translated to PDB amino acid positions and therefore mapped onto the PDB structure. 
